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vForeword
There has been a major increase in substance misuse over the past couple 
of decades and a corresponding increase in the numbers detained in police 
custody who misuse substances. Most of these detainees are vulnerable 
individuals and the recognition of their substance use problems is now 
perceived as important and is receiving local and national attention.
Accurate assessment of morbidities associated with substance misuse, 
including the degree and severity of dependence, and of the need for medical 
intervention is essential, because both intoxication and withdrawal can put 
detainees at risk of medical, psychiatric and even legal complications. Many 
such detainees have not received the treatment and care in custody that they 
need because it is particularly difficult to undertake a proper assessment 
and initiate an appropriate response in the environment in which they are 
seen. However, a detained substance-dependent person who is at risk of 
complications is entitled to the same quality of healthcare as they would 
receive in other locations.
The first edition of these guidelines was produced by a Joint Working 
Group chaired by Professor Hamid Ghodse and comprising representatives 
of the Association of Police Surgeons, relevant Colleges and Faculties, the 
Department of Health and the Home Office. The Association of Police 
Surgeons developed into the Association of Forensic Physicians, then in 
2006 into the Faculty of Forensic and Legal Medicine of the Royal College of 
Physicians of London. This Working Group has now revised the guidelines, 
bringing them up to date and providing an excellent text for forensic 
physicians, other doctors and the staff of law enforcement agencies who 
are involved in care of detainees with substance misuse.
The guidelines recognise that the assessment and treatment of substance 
misusers present forensic physicians with particular challenges that require 
certain skills and experience to ensure appropriate management. They stress 
the importance of good communication, of working closely with custody 
officers and of shared responsibility for the safety and care of detainees with 
substance misuse. In particular, they stress the importance of:
 the full participation of forensic physicians in all aspects and at all stages 
of the healthcare of detainees with substance misuse/dependence
vi
 providing advice to custody officers and others involved with detainees 
with substance misuse/dependence
 comprehensive contemporaneous records 
 appropriate sharing of information in accordance with the law and the 
General Medical Council’s advice on professional confidentiality
 being aware when making all interventions that the interests of the 
detainee as a patient are paramount.
We believe that these guidelines will be of immense value to all 
practitioners in helping and supporting detainees and that they will also 
be useful for teaching purposes for medical and nursing staff and arrest 
referral officers. We congratulate the Working Group on its hard work in 
preparing them.
Dr Dinesh Bhugra, President, Royal College of Psychiatrists 
Dr Iona Heath, President, Royal College of General Practitioners 
Professor Ian Wall, President, Faculty of Forensic and Legal 
Medicine, Royal College of Physicians 
Mr John Heyworth, President, College of Emergency Medicine
May 2011
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Preface to fourth edition of the Guidelines
Addicted individuals should always be cared for and treated without being 
stigmatised, whatever their particular circumstances. For those individuals 
who become casualties of substance misuse and are in police custody, these 
guidelines offer a humane response, with provision for care and treatment. 
They are flexible tools designed to accommodate changes in the nature 
and extent of substance misuse in the community, as well as changes in 
national policy and strategy, together with new developments in the care 
and management of susbtance-dependent individuals. 
Throughout these guidelines it is made clear that the treatment of 
substance misuse should be in line with sound medical practice and 
should not be used as an instrument to establish or maintain control. The 
criminal justice system should offer substance misusers an opportunity for 
treatment and recovery. The overriding principle of care for offenders who 
are substance misusers and who are in custody must be their safety and the 
treatment of suffering that occurs as a result of substance intoxication or 
withdrawal. When care is delivered to a high standard, the correct balance 
will be achieved between different factors such as the need for due process 
in proceedings to safeguard civil rights, treatment needs and other humani-
tarian requirements as well as enforcement objectives. 
Since the third edition of the Guidelines, there have been a number of 
initiatives and developments in services for substance misusers and in the 
criminal justice system in support of treatment and prevention. There has 
been a greater presence and contribution by other healthcare professionals 
working closely with doctors. The fourth edition has responded to these 
developments and I am sure that future editions will demonstrate similar 
responsiveness.
Previous editions of the Guidelines were very well received by all those 
who have been dealing with detainees in police custody.
Like previous editions, this one has been developed through meetings 
of a working group whose members included representatives from various 
health professionals involved in the care of the detainees in police custody. 
They demonstrated tremendous dedication and hard work. Once again, 
the efforts and enthusiasm of Dr Margaret Stark (a Past President of the 
xAssociation of Forensic Physicians) and the Founding Academic Dean of the 
Faculty of Forensic and Legal Medicine of the Royal College of Physicians 
of London have been inspiring and key to the quality of the Guidelines. The 
administrative support of Alex Crowe warrants special acknowledgement. 
The efforts of the publishing department of the Royal College of 
Psychiatrists in the production of the Guidelines are greatly appreciated. 
The support of the Department of Health, particularly Dr Mark Prunty, 
both for invaluable contribution to the text as well as for the dissemination 
of the Guidelines is acknowledged.
Hamid Ghodse
 May 2011
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Preface to third edition of the Guidelines
Since the second edition of the Guidelines there have been a number 
of initiative developments in services for substance misusers and in the 
clinical justice system in support of treatment and prevention. Although 
the outcome of some of these initiatives is not yet clear, there is now a 
greater emphasis on diverting those in conflict with the law from custodial 
sentences towards treatment. Previous editions of these guidelines were 
very well received by all those who have been dealing with detainees in 
police custody.
This latest edition has taken account of those individuals who, 
subsequent to custody by the police, are sentenced to prison and those 
individuals with mental disability whose substance misuse brings them in 
conflict with the law.
Like previous editions, this one has been developed through a limited 
number of meetings of a working group whose members demonstrated 
tremendous dedication and hard work. Once again the efforts and 
enthusiasm of Dr Margaret Stark (the Past President of the Association 
of Forensic Physicians) have been inspiring and key to the quality of the 
Guidelines. The unfailing and skilful administrative support of Candace 
Gillies-Wright warrants special acknowledgement.
The efforts of the publishing department of the Royal College of 
Psychiatrists in the production of the Guidelines is greatly appreciated. The 
support of the Department of Health, particularly Dr Mark Prunty, both 
for invaluable contribution to the text as well as for the dissemination of 
the Guidelines is acknowledged.
Hamid Ghodse
 March 2006
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Preface to second edition of the Guidelines
The constant changes in different aspects of substance use problems and 
the associated responses necessitate the revision of previous texts of these 
guidelines. The Association of Police Surgeons recognised this need and 
suggested that the Royal College of Psychiatrists and the Chairman of the 
Working Group for the first edition should undertake this task. There was 
a short delay until the general guidelines on clinical management (Drug 
Misuse and Dependence: Guidelines on Clinical Management) had been 
published. Those guidelines refer to doctors who are involved in the 
management of individuals in police custody and therefore made the need 
for revision more pressing.
As the first edition of the Guidelines had been very well received, it 
seemed appropriate to update them by revision rather than by wholesale 
rewriting, and the Working Group adopted a similar approach to this 
task as that used on the previous occasion. A limited number of meetings 
were planned and the consultation process was conducted speedily but 
thoroughly. Alcohol has been included in these revised guidelines, and 
sections on fitness to be interviewed and reliability of confession have been 
extended. The wholehearted participation and generous contributions of 
all members of the Working Party must be acknowledged with gratitude. 
Dr Margaret Stark’s work as rapporteur and the efforts of Gill Gibbons of 
the Royal College of Psychiatrists, as an administrator par excellence, warrant 
special mention, as do the encouragement and support of Dr Knight of the 
Association of Police Surgeons and the contribution of Dr Guy Norfolk.
It only remains to emphasise that the principles articulated in the 
preface to the first edition about the nature and purpose of the Guidelines 
remain unchanged and are the benchmark for the second edition. The 
Working Group would appreciate feedback from all those who use the 
Guidelines so that the suggestions and amendments can be incorporated 
into future revisions.
Hamid Ghodse 
February 2000
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General preface
The development of this document was initiated by the Association of 
Police Surgeons, and the process of achieving consensus across the medical 
profession got off to a good start with an excellent conference organised by 
forensic physicians in 1993. It owes much to the dedication and hard work 
of a number of forensic physicians, particularly Dr Margaret Stark, and to 
the untiring efforts of the President of the Association of Police Surgeons, 
Dr Ralph Lawrence. Wide-ranging discussion among forensic physicians 
attending the diploma courses in addictive behaviour at St George’s Hospital 
Medical School also formed a valuable contribution.
It should be emphasised that this document was not devised as a set 
of instructions to be applied in every situation; rather, it is intended as 
an umbrella, briefly describing the general principles of management of 
individuals detained in custody and suffering from problems of substance 
misuse. The Guidelines, therefore, do not necessarily cover every situation 
which may arise, and, where its recommendations are insufficiently detailed 
or specific, the doctor in charge is advised to consult standard textbooks or 
seek specialist advice. This is of particular importance where children are 
involved, when reference should always be made to child psychiatrists. It 
should also be stressed that the document is not meant to define immutable 
regulations or the standard required for excellence. As its name implies, 
it only offers guidelines, and the principles that it endorses indicate good 
and adequate standards of care.
Finally, it should be noted that the Guidelines have received the approval 
of the Association of Police Surgeons, the Royal College of Psychiatrists, 
the Faculty of Accident and Emergency Medicine and the Association for 
Accident and Emergency Medicine. The Working Group would like to thank 
the Royal College of Psychiatrists for having sponsored the Group, and for 
having provided the necessary administrative support.
Hamid Ghodse 
1994

11 Introduction
The substantial prevalence of substance misuse in detainees in police 
custody makes guidelines necessary for forensic physicians (police surgeons, 
forensic medical examiners and forensic medical officers) on the acceptable 
minimum standards for the assessment and treatment of drug- and 
alcohol-dependent individuals. Unless such guidelines are explicit and 
are published, it will continue to be difficult to establish what constitutes 
good practice and whether good practice has or has not been followed in 
any particular instance. The Guidelines is not a comprehensive textbook or 
manual for the treatment of substance misuse. Doctors and other healthcare 
professionals should access more detailed information and specialist advice 
about interventions described in the Guidelines (Ghodse, 2010).
1.1 The Working Party
In 1994, the Department of Health published guidelines on the clinical 
management of substance misuse detainees in police custody (Department 
of Health et al, 1994). In April 1999, it published a major update to the 
general drug misuse clinical guidelines, Drug Misuse and Dependence: 
Guidelines on Clinical Management (Department of Health et al, 1999). 
Following this, in 2000, the guidelines relating to police custody were also 
revised (Association of Police Surgeons & Royal College of Psychiatrists, 
2000). A number of legislative changes as well as other developments in the 
management of substance misuse detainees in police custody necessitated 
a further revision in 2006 (Association of Forensic Physicians & Royal 
College of Psychiatrists, 2006). A year later, Drug Misuse and Dependence: 
UK Guidelines on Clinical Management  was updated (Department of Health 
(England) and the devolved administrations, 2007).
In February 2011, the Royal College of Psychiatrists, at the request 
of the Faculty of Forensic and Legal Medicine of the Royal College of 
Physicians of London, convened a working party of relevant organisa-
tions to revise the third edition of the present document, Substance 
Misuse Detainees in Police Custody: Guidelines for Clinical Management. This 
group included representation from the Faculty of Forensic and Legal 
2Medicine, the Royal College of Psychiatrists, the Royal College of General 
Practitioners, the College of Emergency Medicine and the Association of 
Chief Police Officers. The group included officials from the Home Office 
and Department of Health (who consulted with officials of the devolved 
administrations in contributing to the work of the group).
1.2 The Guidelines
1.2.1 Guidelines, not rules
These guidelines are intended to supplement and appropriately amplify, 
but not replace, the Department of Health’s publication Drug Misuse and 
Dependence: UK Guidelines on Clinical Management (Department of Health 
(England) and the devolved administrations, 2007). All doctors who 
are likely to be managing substance misusers should have a copy of that 
publication and be familiar with the advice given. Clinical Management of 
Drug Dependence in the Adult Prison Setting (Department of Health, 2006) 
is also a useful resource, as it addresses some of the unique challenges of 
providing treatment to substance misusers in a secure environment.
The guidelines presented here pay particular attention to aspects of 
management that are unique to the care of substance misusers when in 
police custody.
This document contains recommendations, not rules. It is intended 
that these should be flexible enough to fit into the clinical practice of all 
forensic physicians.
Clinical decisions may vary in accordance with the specific needs and 
circumstances of individual detainees.
The term ‘substance misuse’ is used throughout this document to 
include the misuse of prescribed drugs with dependence potential as well 
as the use of illicit substances, chemicals (such as volatile substances), over-
the-counter medicines and alcohol.
1.3 The scope of the problem
Substance misuse is a substantial and growing problem. Forensic physicians 
are increasingly being asked by the police to assess substance misusers with 
respect to their fitness for detention, need for treatment and fitness for 
3interview. According to the British Crime Survey for 2009–2010, 8.6% of 
adults and 20% of young people aged 16–24 years had used an illicit drug 
in the past year (Hoare & Moon, 2010). Therefore, all detainees should be 
asked about substance misuse, including alcohol and benzodiazepines, so 
that early intervention can be provided (HM Government, 2010).
The Arrestee Survey (Boreham et al,  2007) is a nationally representative 
survey of drug use and crime among individuals arrested in England and 
Wales. Three cycles of self-reported drug misuse have now been collected, 
and the most recent, for 2005–2006, shows that 52% of all respondents 
reported having taken one or more drugs in the month before arrest; 
cannabis was the most widely taken drug, with 41% having taken it in the 
previous month, followed by heroin and powder cocaine (13%), crack 
cocaine (11%) and ecstasy (8%). 
1.4 Changing provision of forensic medical services
In recent years, the provision of clinical forensic medical services has 
radically changed from the traditional doctor-only model. Forensic 
physicians now work more commonly in multidisciplinary teams with 
nurses and paramedics. The Home Office published a circular amending 
the Codes of Practice of the Police and Criminal Evidence Act 1984 
(PACE) to allow other healthcare professionals to perform many of the 
roles previously carried out by registered medical practitioners (Policing 
& Crime Reduction Group, 2003). These Codes cover the jurisdictions of 
England, Wales and Northern Ireland. Similar changes have been effected 
in Scotland (HM Inspectorate of Constabulary for Scotland, 2008), where 
the Chief Executive has also emphasised the importance of partnership 
working in a letter to all NHS Board Chief Executives (Dr Kevin Woods, 
personal communication, 5 December 2008). The Act and the associated 
PACE codes (Home Office 2011) are different in the islands of Jersey (the 
Police Procedures and Criminal Evidence (Jersey) Law 2003) and Guernsey 
(the Police Powers and Criminal Evidence (Bailiwick of Guernsey) Law 
2003) and so practitioners should make themselves fully aware of local 
variation. In the Isle of Man, the Police Powers and Procedures Act 1998 
is the relevant legislation. 
In the Home Office circular, the term ‘healthcare professional’ refers 
to a clinically qualified person who is working within the scope of practice 
4as determined by their relevant professional body (General Medical 
Council, Nursing and Midwifery Council, Health Professions Council) 
and who is registered with that body as competent to practice (Policing & 
Crime Reduction Group, 2003). The circular contains guiding principles 
on recruitment and management, professional independence, clinical 
supervision, clinical governance, confidentiality and disclosure in relation 
to individual records and treatment. 
Any healthcare professional working in the custody environment must 
be appropriately trained and work within the scope of their professional 
competency and according to recommended clinical guidelines.
The Faculty of Forensic and Legal Medicine of the Royal College of 
Physicians of London was formally established in 2006 to: 
 promote for the public benefit the advancement of education and 
knowledge in the field of forensic and legal medicine
 develop and maintain for the public benefit the good practice of forensic 
and legal medicine by ensuring the highest professional standards of 
competence and ethical integrity.
The Faculty has produced quality standards for doctors working in the 
field of forensic medicine (Faculty of Forensic and Legal Medicine, 2010a) 
and is now working on similar standards for other healthcare professionals. 
National occupational standards for healthcare professionals working in 
police custody have also been developed (Skills for Health, 2007). 
The statutory responsibility to ensure that detainees have access to 
appropriate healthcare while in custody is that of the Chief Officers of 
Police (National Centre for Policing Excellence, 2006). Her Majesty’s 
Inspectorate of Prisons and Her Majesty’s Inspectorate of Constabulary 
have also published criteria for assessing the treatment and conditions for 
detainees in police custody (HM Inspectorate of Prisons & HM Inspectorate 
of Constabulary, 2009). Their expectations include that detainees have 
access to competent healthcare professionals working within robust clinical 
governance arrangements, which include initial and ongoing training, 
supervision and support. 
It is essential that robust clinical governance procedures are developed 
for the provision of clinical forensic medical services covering training in the 
area of substance misuse and mental health and ensuring that individual 
practitioners have the competencies to perform the role that they are 
required to perform, with clear protocols as to who to refer to and when. 
52 History and examination
2.1 What is required?
2.1.1 Liaison with custody staff
Early and effective liaison with the police custody officer can yield relevant 
information, particularly about the circumstances of the arrest, the 
behaviour of the detainee on arrest and whether any physical restraint was 
used, and the extent to which the detainee has been searched and whether 
any substances were found.
The custody officer may already have valuable information about the 
detainee’s medical condition and needs, and may also be able to provide 
details of any risk assessment that has been conducted. The forensic 
physician should ask the custody officer how long the person is likely to 
be detained and if and when he or she is likely to be interviewed, if the 
information is currently available.
2.1.2 History and examination
Careful and well-documented history-taking and examination (including 
mental state examination) are essential to provide safe and effective care 
for the detainee and to establish the degree of substance misuse and/or 
dependence (Fig. 2.1). 
Forensic physicians should explain their role as independent medical 
practitioners. Consent for the examination should be obtained after an 
explanation of the nature and purpose of the examination. The doctor 
must be satisfied that the patient can comprehend and retain the relevant 
information, believes the information and can weigh up the pros and 
cons in order to arrive at a choice (Re C (Adult: Refusal of Treatment), 1994). 
Consideration should be given as to whether the detainee has the capacity 
to consent. For example, intoxicated or young detainees may not have this 
capacity. In a genuine emergency, where there is no possibility of obtaining 
consent, forensic physicians have a duty to carry out treatment to safeguard 
the life and health of the patient in accordance with what would be accepted 
as appropriate treatment in the patient’s best interests, in keeping with the 
doctrine of necessity.
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7Capacity to consent may also be affected by the presence of mental 
disorder, including learning (intellectual) disability or other developmental 
disorder such as autism. If this is suspected, the assistance of an ‘appropriate 
adult’ may be required (also see section 3.2.6). If the person is living in a 
supported setting, it is important to obtain their agreement to inform their 
carer (family member or paid staff) of their detention.
All substance misuse detainees, but particularly those from ethnic 
minorities, are vulnerable as, in addition to possible medical problems 
associated with substance misuse, they might be charged and convicted 
of drug offences. There is even greater vulnerability if the detainee is 
from overseas and has immigration and/or language problems. Forensic 
physicians may have to examine a person who is a foreign national or whose 
first language is not English. Police forces often use interpreters in these 
situations and their help may be required during an assessment.
The history should cover details of past and present drug use, including 
alcohol. The following information should be obtained:
 type(s) of substance(s) misused
 duration of substance misuse
 quantity taken per day, on an average/typical day and/or amount spent 
on substances 
 frequency of use
 route of administration (noting any sites of injection)
 amount used in the past 24–48 hours 
 the time of the last dose(s).
The detainee should be asked about any history of treatment for misuse 
and its effectiveness, as well as previous experience of withdrawal symptoms 
and physical and psychological consequences. It is particularly important to 
know whether the detainee is currently receiving treatment and medication 
as part of an opioid substitution detoxification or maintenance programme. 
Specific enquiry should be made about the concomitant use of other 
substances (including those legitimately prescribed and details of the 
source of supply) and alcohol. This should be an active enquiry, as alcohol 
dependency is often not recognised or reported by users of other substances. 
Alcohol withdrawal complicates other presenting symptoms and signs and 
carries a significant morbidity and mortality if untreated.
8Physical examination should involve looking for signs of intoxication, 
dependence or withdrawal. Mental state examination should include 
assessment of disorders of speech, mood, perception, thought, cognitive 
function, insight and risk of self-harm. The risk of self-harm is increased 
during withdrawal, when individuals may have a tendency to impulsive and 
volatile behaviours. Women are at particularly high risk of self-inflicted 
death during the early period of prison custody, and self-harm is 14 times 
more common among women than men during their prison term(Møller 
et al, 2007: pp. 159–160). 
Assessment of an intoxicated individual whose first language is not 
English through an interpreter poses particular challenges. Mental state 
examination needs particular care when trying to interpret disorders of 
speech and thought.
At the conclusion of the examination, the forensic physician should 
clearly inform the custody officer about any future medical needs of the 
detainee and should ensure that this information is included in the police 
medical record form. If the doctor identifies any specific risk in relation 
to the detainee (for example, linked to their medical or mental condition, 
their use of drugs or alcohol or any propensity for self-harm), the doctor 
should ensure that these are clearly drawn to the custody officer’s attention 
verbally and in writing.
Detailed contemporaneous notes should be made of any consultation 
with a detainee. If the detainee is transferred, a copy of the medical record 
form should be sent with the detainee; this is especially important where 
medication has been prescribed or authorised.
2.2 Reliability of histories
2.2.1 In therapeutic situations
Studies have shown that substance misusers who are involved in opioid 
substitution maintenance programmes are generally honest when reporting 
recent drug use: the accuracy of self-reported drug use has been reported 
at over 80% (Brown et al, 1992), although there are also reports of 
exaggeration and underestimation of misuse.
92.2.2 In police custody
Frankness on the part of substance misusers while in custody regarding 
their history of misuse appears less common. Inconsistent information may 
be given in an attempt to acquire some perceived secondary gain, and can 
pose particular risks when a forensic physician is required to initiate any 
medication.
Many substance misusers have negative perceptions of their medical 
management while detained in police custody (Gregory, 2007).
Honesty is more likely if the detainee feels confident of a sympathetic 
hearing and the availability of effective care. Forensic physicians should 
stress their independence from the police by making it clear that, like any 
other doctor, they are concerned about the physical and mental care of their 
patient. It is essential that forensic physicians remain non-judgemental and 
non-confrontational. Detainees have the right to refuse to be examined by 
a forensic physician and then have the right to be examined by a medical 
practitioner of their own choice at their own expense.
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3 Principles of medical management
3.1 General considerations
3.1.1 The rights of detainees
Individuals in police stations are entitled to the same standard of medical 
care as any other member of the public. Forensic physicians need to 
give careful attention to the issue of the consent of a detainee to any 
examination. Detainees have the right to have prescribed medication 
continued while in custody, as long as it is clinically safe to do so. Detainees 
should be informed of the outcome of the assessment and the consequent 
clinical decisions.
3.1.2 Clinical safety of detainees
The overriding consideration of the attending forensic physician is the 
clinical safety and well-being of the detainee.
Detainees should be assessed for signs of intoxication and/or withdrawal 
and prompt attention paid to any acute medical needs. It should be 
remembered that the onset of signs of overdose with certain substances 
(for example, methadone or other substances swallowed immediately 
before arrest in order to escape detection, see Section 3.6.2) may not be 
immediately obvious and may occur later.
Instructions should be given to the custody staff that intoxicated 
detainees should be visited and roused at least every half hour and have 
their condition assessed as in Appendix A. The purpose of recording a 
person’s responses when attempting to rouse them using this procedure is 
to enable any change in their level of consciousness to be noted and clinical 
treatment arranged if appropriate. If the custody staff have any concerns 
regarding the level of consciousness of an intoxicated detainee, they should 
be advised to obtain urgent medical attention.
Assessment of the mental state is also an essential part of risk 
management, especially in respect of self-harm.
Although treatment to limit or prevent the withdrawal syndrome may 
seem desirable (see Chapter 5), before such treatment is initiated the 
forensic physician must be satisfied that the detainee is not under the 
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influence of any other substance, including alcohol, that might significantly 
alter the action of the prescribed medication, thus making it unsafe. Doctors 
must be alert to the dangers of over-prescribing substitute drugs. 
The prescribed dose of a drug may not accurately indicate the true 
amount taken per day; for example, part of the prescribed medication 
may be given to other misusers, and drugs from illicit sources may be used 
in addition to prescribed drugs. Before any medication is administered 
in police custody these possibilities must be reviewed and additional 
safeguards (such as the provision of smaller, divided doses) should be 
considered to reduce any risk.
It may be useful to check any available police records regarding previous 
medical examinations, for example National Strategy for Police Information 
Systems (NSPIS) medical forms. Where care is delivered through the NHS 
it may be possible to access the emergency care record with the detainee’s 
consent.
3.1.3 Detainees’ expectations
Suitable treatment may not necessarily involve the prescribing of a substitute 
for the drug of dependence, although this may be the case.
Detainees must be helped to understand that a prescription is not always 
necessary or useful, but that effective drugs will be prescribed if appropriate.
The treatment requested by a drug misuser may be different from the 
treatment that the doctor judges to be appropriate. Addiction often leads 
to confusion between good care and a ready supply of drugs.
3.2 Mental disorder
3.2.1 Mental illness and substance misuse
Mental state examination is important for the general care of the detainee. 
For example, there may be depression, psychosis or other psychiatric 
conditions requiring treatment. When assessing the mental state of an 
individual, the forensic physician will need to decide whether to obtain 
the opinion of a psychiatrist, and if so, when.
Examination of mental state is particularly important medico-legally 
because if drug (for example, amphetamines, cocaine or cannabis) or 
alcohol use gives rise to a psychotic state, this may have implications for 
the offence or affect fitness for interview.
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Comorbidity of severe mental illness and substance misuse is common, 
for example a diagnosis of schizophrenia may coexist with a diagnosis of 
drug dependence. Drug use can cause rapid worsening of mental state even 
in stabilised psychotic illness. Substance misuse may be associated with a 
psychotic state through a number of mechanisms. Intoxication may mimic 
psychosis, which may be triggered by stimulants (Ghodse & Kreek, 1998) 
and cannabis (Ghodse 1986; Mathers & Ghodse, 1992). A psychotic state 
may arise that persists beyond the elimination of the drug. Withdrawal 
states such as those seen with alcohol or benzodiazepines may result in 
vivid hallucinations and clouding of consciousness.
Substance misuse may also be associated with other psychiatric 
conditions, including affective disorders such as depression, that can result 
in acts of self-harm, suicide and aggressive behaviour. This is a particular 
problem following stimulant withdrawal. Detainees with a diagnosis of 
attention-deficit hyperactivity disorder (ADHD) who have been prescribed 
stimulants or any other medication should have this continued in custody.
3.2.2 Risk of suicide and self-harm
Research has shown that episodes of self-harm typically occur soon after 
arrest (Ingram et al, 1997) and that particular risk factors include histories 
of self-harm, psychiatric illness (Ingram et al, 1997; Norfolk, 1998) and 
addiction (Oyefeso et al, 1999). The risk is higher in women in a custodial 
setting. 
A risk assessment should be made as part of the mental state assessment 
(e.g. National Collaborating Centre for Mental Health, 2004). If referral 
to an emergency department (formerly known as A&E) is not necessary 
(for self-injury or self-poisoning), any consideration of urgent referral to 
secondary mental health services should be based on a risk and needs 
assessment. This would include: the social and psychological aspects of 
self-harm; mental health and social needs; hopelessness; and suicidal intent.
Where such assessments highlight a risk of self-harm, the forensic 
physician should inform the custody officer and provide him or her (within 
the bounds of patient confidentiality; General Medical Council 2009) with 
sufficient information to allow the custody officer to give the necessary 
care to the detainee and to meaningfully communicate risk to others. 
Detailed assessments should be undertaken of detainees who express a 
clear intention of self-harm, with attention given to any evidence of previous 
acts of self-harm.
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3.2.3 The Mental Health Acts
Compulsory admission to hospital under the Mental Health Act 1983 
(England and Wales) as amended in 2007, the Mental Health (Northern 
Ireland) Order 1986, or the Mental Health (Care and Treatment) 
(Scotland) Act 2003 may be justified for a substance misuser who has a 
mental disorder, including mental disorders precipitated by or associated 
with substance misuse. Substance misuse and dependence alone are not, 
however, sufficient grounds.
A patient may be detained in hospital under the Acts where certain 
criteria have been met, including where detention is necessary in the 
interests of their own health or safety or for the protection of other people.
3.2.4 Learning (intellectual) disabilities
Learning (intellectual) disability includes the presence of a significantly 
reduced ability to understand new or complex information, to learn new 
skills (impaired intelligence) and to cope independently (impaired social 
functioning), which started before adulthood and has a lasting effect on 
development. This definition encompasses people with a broad range of 
disabilities.
3.2.5 Liaison with local psychiatric services
Detainees with substance-related problems who are transferred to general 
hospitals for physical treatment often have associated psychiatric problems 
which may need treatment in their own right. It is important that the 
forensic physician communicates clearly with the psychiatric services as 
well as with the medical and surgical teams.
The Home Office encourages the police service to form effective 
arrangements with local health services to ensure their speedy involvement 
when a person in custody is suspected of having a mental disorder. It would 
be helpful for the forensic physician to establish whether such links exist 
locally, since these should improve relationships with psychiatric services, 
including policies in relation to application of Section 136 of the Mental 
Health Act 1983.
Local arrangements for liaison between the police, forensic physicians 
and psychiatric services vary widely. Whatever local arrangements apply, 
there must be effective communication at an individual and policy level 
between the parties involved.
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3.2.6 Appropriate adults
In England and Wales, if a person in police detention is a juvenile, i.e. is 
or appears to be under the age of 17 (under 18 years of age in Northern 
Ireland), mentally disordered or otherwise mentally vulnerable, or mentally 
incapable of understanding the significance of questions or their replies, 
then the custody officer must inform an ‘appropriate adult’ and ask that 
adult to come to the police station to see the person. A history of substance 
misuse alone is not an indication that an appropriate adult needs to be 
present.
The appropriate adult is often the person’s parent or guardian or a social 
worker. However, where there are no other suitable candidates available, 
it can be any responsible adult aged 18 years or over who is not a police 
officer or employed by the police. 
If there is evidence of mental disorder, as defined by the respective 
Mental Health Acts, then an appropriate adult will be required as set out 
in Code of Practice C issued under the Police and Criminal Evidence Act 
1984 (PACE; Home Office, 2006). The PACE Code applies in England, 
Wales and Northern Ireland. In Scotland, recommendations regarding the 
calling in of an appropriate adult are given in the Scottish Office Police 
Circular 7/1998 (Scottish Office, 1998).
A key purpose of the appropriate adult is to advise the detainee during 
questioning, to observe whether or not the interview is being conducted 
properly and fairly, and to facilitate communication with the detainee. 
More broadly, the appropriate adult is in a position to assist and support the 
detainee to ensure that their rights are respected and that they understand 
what is happening and why.
It is the duty of the custody officer to decide whether to call an 
appropriate adult. However, if a doctor should become aware at any 
stage that a detainee falls into one of the relevant categories, they should 
ensure that a record is made and confirm with the custody officer that an 
appropriate adult has been or will be called.
3.3 Special considerations concerning female detainees
3.3.1 The pregnant drug addict
Sudden cessation of opioid use in a dependent pregnant woman may be 
life-threatening for the fetus.
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The need to safeguard the patient and her pregnancy is paramount. 
It is important to consider whether or not a female detainee is pregnant 
before initiating treatment. A pregnancy test should be performed (with 
consent), if required after risk assessment, on women of child-bearing age 
who are being assessed for alcohol and/or drug dependence. Amenorrhoea 
is associated with substance misuse, so it is not unusual for women to be 
unaware that they are pregnant. 
Some women will know that they are pregnant but will not have attended 
for antenatal care and may be unaware of the gestation of their pregnancy. 
Practitioners should have a high index of suspicion to test and seek consent 
to test, after explaining the risks.
Special care should be taken to ensure that pregnant women with 
substance misuse have their prescribed medication continued while in 
custody, as they are at high risk in terms of pre-term delivery, obstetric 
complications and poor outcomes for both the fetus and the mother.
There is a need to avoid withdrawal and intoxication, and therefore 
stabilisation of a pregnant detainee in custody may not be possible. Forensic 
physicians should have a low threshold for early referral to hospital for 
obstetric assessment and substance misuse treatment. 
A pregnant woman who shows signs of marked withdrawal and/or 
intoxication on arrival should be transferred to hospital for assessment 
and initial stabilisation.
Cocaine use carries risks to the fetus, including premature labour and 
placental abruption, and risks to the mother, especially those of fluctuations 
in blood pressure.
3.4 Special considerations concerning young people under 
18 years of age (Crome et al, 2004; Mirza & Mirza, 2008)
3.4.1 Special characteristics
Among young people, the most commonly used drugs are cannabis and 
alcohol, and a substantial minority use multiple drugs. There is an earlier 
age of initiation into drug use than previously, with roughly equal frequency 
of use in boys and girls. Young people who engage in problematic substance 
use have a greater than average likelihood of coming from a dysfunctional 
family and are at risk of multiple disadvantage, including criminality, 
unemployment, truancy, and social and economic deprivation. Many 
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young substance misusers have multiple antecedent and co-occurring 
mental health problems, self-harm and unrecognised learning difficulties, 
and many are not in employment, education or training. Thus, young 
people who find their way into police custody often present with multiple 
complex needs, including child protection concerns, and their reports or 
claims regarding substance misuse should be thoroughly assessed and not 
disregarded.
Although the majority of young people who misuse substances might 
not suffer serious harmful consequences, a significant minority will develop 
substance dependence, as well as physical and/or psychiatric comorbidity 
whether or not they are dependent.
Common comorbid psychiatric disorders include conduct disorders, 
depression, post-traumatic stress disorder and attention-deficit disorder 
(with or without hyperactivity). A small minority present with eating 
disorders and psychosis. Rates of self-harm are high, including self-cutting 
and overdose. Children who present with comorbid disorders are at very 
high risk, and the combination of depression, conduct disorder and 
substance misuse is particularly suggestive of self-harm, with substance 
misuse the most powerful of the three factors (Zeitlin, 1999).
In assessing a young person, the forensic physician should enquire about 
current substance misuse and mood problems as well as a past episodes of 
self-harm, as this may be an indicator of risk of self-harm while in custody. 
Young people are engaging in more binge drinking (defined as more 
than 5 units at one sitting), and the incidence of drunkenness at least 
once in the past 30 days has risen. It has been found that 5–10% of both 
boys and girls aged 14–15 years are drinking more than the recommended 
levels for adults. As binge drinking and occasional drunkenness are more 
frequent than sustained high levels of consumption, forensic physicians 
should enquire about drinking patterns, including frequency and 
quantities consumed over time. Even though alcohol dependence is rare 
in young people, a substantial minority show problematic alcohol use and 
individuals should be questioned about the impact of alcohol use on their 
lives, including getting into fights/arguments, getting into trouble with the 
police and driving while drunk. 
The forensic physician should take a detailed drug history, as young 
people who come into custody show higher likelihood of using multiple 
drugs, including cocaine, ecstasy, ketamine, volatile inhalants, newer 
synthetic drugs and benzodiazepines. 
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3.4.2 Issues regarding consent 
The following section is taken from the Faculty of Forensic and Legal 
Medicine’s (2008) Recommendations: Consent from Children and Young People 
in Police Custody in England and Wales (amended with permission).1
The legal position concerning consent and refusal of treatment and 
examination by detainees under the age of 18 is different from that for 
adults. In the following paragraphs the terms ‘child’ and ‘young person’ 
are used interchangeably.
3.4.2.1 Therapeutic examinations
In the UK, children become adults for medical, that is therapeutic, purposes 
at age 16, at which age they are entitled to consent to their own medical 
treatment. As for adults, consent will only be valid if an appropriately 
informed patient capable of consenting to the particular intervention 
gives it voluntarily.
Children under the age of 16 may have the capacity to consent to medical 
treatment if they have sufficient understanding and intelligence to enable 
them to comprehend fully what is involved in the proposed intervention. 
This is sometimes described as being ‘Gillick competent’, where such a 
decision in England and Wales is based on case law, including this landmark 
authority (Gillick v. West Norfolk & Wisbech Area Health Authority, 1985). 
In England, Wales and Northern Ireland, if a young person of 16 or 17, 
or a child under 16 but Gillick competent, refuses treatment, such a refusal 
can be overruled either by a person with parental responsibility for the child 
or by the court. This power to overrule must be exercised on the basis that 
the welfare of the young person is paramount.
In contrast, in Scotland the Age of Legal Capacity (Scotland) Act 1991 
states that if, in the opinion of the registered medical practitioner, the 
young person understands what medical treatment is proposed and its 
likely consequences, then they have the requisite capacity and their refusal 
of treatment cannot be overruled. 
A life-threatening emergency may arise in which consultation with a 
person with parental responsibility or the court is impossible. If a young 
1. Prepared by Dr Peter Franklin and Dr Guy Norfolk and reproduced with 
permission of Drs Stark, Rogers and Norfolk, March 2008. Updated by Dr George 
Fernie, April 2011 on behalf of the Academic Committee of the Faculty of Forensic 
and Legal Medicine. © April 2011, Faculty of Forensic and Legal Medicine. 
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person refuses consent in such circumstances, any doubt should be resolved 
in favour of the preservation of life and it is acceptable to undertake 
treatment to preserve life or prevent serious damage to health wherever 
that scenario arises within the UK.
3.4.2.2 Forensic examinations
Although not decided in law, it is reasonable to assume that young people 
aged 16 or 17 have the capacity to consent to a forensic examination just 
as they do to a therapeutic examination. 
However, in addition to gaining consent from the juvenile, when a 
forensic examination is going to be carried out on a child younger than 
16 it is good practice to inform and obtain the consent of a person with 
parental responsibility whenever reasonably practicable. Obtaining such 
consent is essential if the child is not Gillick competent. Likewise, in 
Scotland it would be considered good practice to involve an individual 
with parental responsibility even if the mature minor appears to have the 
capacity for a therapeutic process in terms of the Age of Legal Capacity 
(Scotland) Act 1991.
Forensic physicians need to be aware that there are additional procedural 
considerations with regard to forensic examinations of young people. In 
the eyes of the Police and Criminal Evidence Act 1984 (PACE), juveniles 
become adults at age 17 and thus 17-year-olds can give consent. However, 
when dealing with detainees under this age, the police are required to 
follow certain rules to ensure that evidence obtained from juveniles in 
custody is legally admissible in court.
The rules with regard to obtaining intimate samples from a detained 
person require ‘appropriate consent’ in order for the intimate sample 
evidence to be admissible. ‘Appropriate consent’ is defined in Section 65 
of PACE as meaning:
(a) in relation to a person who has attained the age of 17 years, the consent 
of that person;
(b) in relation to a person who has not attained that age but has attained 
the age of 14 years, the consent of that person and of their parent or 
guardian; and
(c) in relation to a person who has not attained the age of 14 years, the 
consent of their parent or guardian. 
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Where the consent of a parent or guardian is required, it is not necessary 
for that person to be at the police station to give that consent. However, 
where the consent of the juvenile is required, it must be obtained in the 
presence of an appropriate adult, who may be the parent or guardian or 
some other suitable person over the age of 18 years.
The decision as to which other forensic examinations require the 
presence of an appropriate adult when consent is obtained from a juvenile 
is essentially a matter for the police and not the forensic physician.
3.5 Special considerations concerning people with learning 
(intellectual) disabilities
Substance misuse is uncommon among people with learning (intellectual) 
disabilities (Huxley et al, 2007), partly because many live supervised lives 
and partly because most cannot afford it. Those that do engage in misuse 
face significant problems. They can be very suggestible and easily caught, 
and may take the blame for others. Police officers do not routinely screen 
for and may not recognise when individuals have learning disabilities. The 
suggestibility of such individuals is not well understood and police officers 
rarely ensure adequate legal protection for these vulnerable individuals, or 
adequate support to enable them to cope with the stress of being interviewed 
(Gudjonsson, 2010). 
Many detainees with learning disabilities are known to a care giver or 
care-giving organisation and/or to a community learning disability team. 
Their problems are often of a serial and relentless nature, requiring a 
strategic and multi-agency response. Efforts should be made to contact 
people who know the detainee and their context, rather than relying on 
the minimum of an ‘appropriate adult’.
3.6 Liaison with other agencies
3.6.1 General medical problems
Substance misusing detainees may have other medical problems, related or 
unrelated to substance misuse (for example, a recent head injury), which 
require hospital treatment. Forensic physicians should ensure that serious 
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concurrent problems are not overlooked because of a history of substance 
misuse/dependence and should liaise with appropriate colleagues, such 
as the emergency (A&E) department, obstetrician or medical team. 
Communication should preferably be both oral and confirmed in writing.
The doctor responsible for the discharge of the patient from hospital 
should ensure that relevant confidential medical information is transferred 
with the detainee (General Medical Council, 2006) (by letter, copy of 
electronic discharge summary, or completion of any appropriate forms, e.g. 
Appendix B). The police should also be given any necessary information 
to ensure the safe transfer and care of the detainee while in police custody. 
It is a matter for the custody officer to determine whether further medical 
advice should be sought from the forensic physician on the detainee’s 
return to the custody suite.
3.6.2 ‘Body stuffers’, ‘body pushers’ and ‘body packers’
3.6.2.1 Definitions
Body stuffers is a term commonly used to describe people who swallow 
illicit drugs (usually in a hurry) to avoid being found with the drugs in 
their possession. The substance may be swallowed loose, or wrapped in 
cling-film, often not very securely.
Body pushers are those who insert drugs into either their vagina or 
rectum, also to avoid being found in possession of drugs. 
Body packers (‘drug couriers’ or ‘surgical mules’) is the term commonly 
used to describe people who swallow packets of illicit drugs or put them into 
body orifices (using condoms or other containers, often purpose designed 
to escape detection) as they pass through customs checks. The packets 
are intended to retain their contents as the individual crosses frontiers. 
However, the packets may leak or rupture at any stage, with the risk of 
severe and potentially fatal toxicity.
Typically, the substances concerned are cocaine or heroin, but other 
drugs may be involved. Diagnosis is based on the presence of symptoms 
and signs on clinical examination. Signs of toxicity may be apparent, and 
packages may sometimes be felt through the abdominal wall or on rectal 
examination.
A near-patient urine or oral-fluid test can be helpful to confirm the 
presence of drugs, but it does not differentiate between smugglers and 
users and, rarely, urinalysis may be negative owing to good packaging. If 
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the urine is positive for cocaine, it is very likely that cocaine is responsible. 
If positive for opioids, the packages may contain heroin, but body packers 
often take opioids such as codeine to slow the bowel during a long flight. 
Thus, a positive test for opioids does not confirm that heroin has been 
taken. Other investigations may be required to confirm the presence of 
packages, including abdominal X-ray, abdominal ultrasound or computed 
tomography scanning.
3.6.2.2 Role of forensic physician
If a detainee states that they have swallowed drugs before arrest, or if the 
arresting officer reasonably believes they have done so, they should be 
conveyed without delay to the emergency (A&E) department of an NHS 
hospital with full resuscitation facilities and treated for a drug overdose 
until this is shown to be otherwise. If a forensic physician is contacted in 
this scenario, he or she should undertake a risk assessment and the custody 
officer should be advised accordingly.
If the detainee is symptomatic, immediate transfer to hospital should 
be made.
In cases of doubt, early and repeated examinations must be undertaken 
using the Custody Early Warning Score (CEWS). The CEWS is an adaptation 
of the Modified Early Warning Score (MEWS), the system recommended 
by the National Institute for Health and Clinical Excellence (Centre for 
Clinical Practice, 2007) for the early recognition of acutely ill patients. The 
CEWS may identify early symptoms of leakage.
Initially, there may be no symptoms and signs of intoxication. It may be 
possible to observe the detainee in the police station for a short period; 
however, it is not appropriate for non-medical personnel alone to conduct 
observation of a detainee over a prolonged interval because they may have 
insufficient knowledge of the symptoms and signs that are cause for concern. 
Detainees who swallow or conceal drugs in their body cavities have 
various motives. Some are simply seeking to dispose of evidence of the 
offence (possession of drugs); others may have an explicit intention of self-
harm of varying degrees of intensity. Sometimes, this arises from the belief 
that the claimed suicidal behaviour will lead to transfer to a psychiatric 
service and an avoidance of criminal charges. If there is evidence that 
suicidal or other self-harming intent lies behind the disposal of drugs in this 
way, the forensic physician should liaise as appropriate with the psychiatric 
assessment service in the general hospital.
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If deliberate smuggling is suspected, an initial assessment by a suitably 
trained forensic physician is recommended. Further detention should only 
occur under suitable conditions. Some aspects of this include enhanced 
training of all custody staff, the ready availability of suitable resuscitation 
equipment, and rapid and easy access to a hospital emergency department 
with full resuscitation facilities. There should be close cooperation between 
custody officers, emergency department staff and hospital security to safely 
manage these patients. 
Whether it is safe for the detainee to be observed in a secure facility 
should be decided after discussion with hospital colleagues. Most body 
packers can be managed conservatively; however, prompt treatment will 
be required should there be clinical signs of deterioration. Indications for 
surgical removal include intestinal obstruction, suspected rupture, and 
drug overdose.
3.6.3 Intimate searches
The Police and Criminal Evidence Act 1984 provides grounds under which 
an intimate search for drugs may be carried out in England, Wales and 
Northern Ireland: such a search requires the authorisation of a police 
officer of the rank of inspector or above, who has reasonable grounds 
for believing that a person has concealed a Class A drug which he or she 
intended to supply to others or to export and that an intimate search is the 
only practicable means of removing it. 
The Faculty of Forensic and Legal Medicine of the Royal College of 
Physicians and the British Medical Association have issued comprehensive 
guidelines for doctors asked to perform intimate body searches (British 
Medical Association & Faculty of Forensic and Legal Medicine, 2010). 
Figure 3.1 outlines the conditions regulating intimate searches in police 
custody. 
In summary, the search must be carried out at a hospital or other medical 
premises (not a police station) by a suitably qualified person (a registered 
medical practitioner or registered nurse). The responsibility for performing 
the examination lies with the forensic physician/nurse and not the hospital 
doctor. Permission to use hospital accommodation should be sought from 
the senior medical/nursing staff at the hospital (in an emergency (A&E) 
department) or other medical premises concerned. It is recommended that 
an emergency department with full resuscitation facilities is used because 
of the potential dangers involved.
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The doctor/nurse must have obtained the detainee’s fully informed 
consent to this examination. A detainee’s competence to make a decision 
may be affected by illness, fear, fatigue, distress or by the effects of alcohol 
or drugs. The doctor/nurse has an important role to play in ensuring that 
whatever decision the individual makes is based on accurate information 
about the options and possible consequences, including the health risks, if 
any, of refusing the search; for example, the risk that a package of concealed 
drugs might split, resulting in an overdose.
In Scotland, if, in the interests of justice and to obtain evidence, it is 
necessary to carry out an intimate search of natural body orifices of (a) a 
person arrested, (b) a person detained under section 14 of the Criminal 
An intimate search is a physical examination of body orifices other than the mouth,  
and could therefore include the ear, nose, rectum or vagina.
It requires the authority of an inspector or above, and that the detainee is arrested,  
in police detention and:
(a) may have concealed anything that 
could be used to cause physical 
injury to self/others or might be 
used while in detention
(b) Class A drug concealed and had 
appropriate criminal intent
and this cannot be found without  
an intimate search.
or
Police officers can carry out an 
intimate search in (a) without 
consent.
Police officers cannot carry out 
an intimate search in (b) with or 
without consent.
A doctor or other healthcare professional can 
carry out an intimate search in (a) and (b), but 
needs valid and informed consent to do so.
Intimate searches in (a) can be carried 
out in a police station.
Intimate searches in (b) must be 
carried out in a medical facility, ideally 
a hospital with resuscitation facilities.
An X-ray or ultrasound can also  
be authorised in (b), but requires 
written consent.
Fig. 3.1 Conditions regulating intimate searches in police custody (from 
Faculty of Forensic and Legal Medicine, 2010b).
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Procedure (Scotland) Act 1995, or (c) a person detained at a police office 
for the purposes of search authorised by statute, then the search can take 
place only under the authority of a Sheriff’s warrant. Where a warrant is 
obtained for this purpose, the search must be carried out by a police surgeon 
in a police medical room or at another suitably equipped premises that the 
police surgeon considers appropriate. A police officer of the same gender 
as the prisoner must be present to corroborate the search.
3.6.4 Liaison with prison
Remand prisons have specialist substance misuse nurses and a 24-hour 
healthcare presence. The assessment and treatment of drug and alcohol 
dependence in this setting tends, therefore, to be more in line with that 
provided in the community than in police custody, where the usually short 
period of detention restricts clinicians to maintaining ongoing medication 
or managing symptoms of withdrawal. Methadone (first line) and, where 
clinically appropriate, buprenorphine are opioid substitutes for managing 
opioid withdrawal in prisons.
To inform clinical assessment in prison, as indicated in Section 2.1 
above, a record of any consultation provided by a forensic physician should 
be made on the police medical record form. If a detainee is transferred to 
court, and subsequently prison, a copy of the medical record form should 
be sent with the detainee. Any medication prescribed should be entered 
on the form. In addition, objective clinical measurements such as pulse 
rate, blood pressure and size of pupils are useful; so too are any initial 
drug screen test results.
If there is concern that a detainee who is due to be transferred to court 
may be at risk of suicide or self-harm, the procedure outlined in Section 
3.2.2 should be followed. Forensic physicians should (within the bounds of 
patient confidentiality) provide custody officers with sufficient information 
to allow them to give necessary care to the prisoner and to meaningfully 
pass on risk warnings. The custody officer will then communicate this 
suicide or self-harm risk warning to escort services, the court and the 
prison (using the Prisoner Escort Record Form). Again, forensic physicians 
should ensure that they make a record of any consultation in the police 
medical record form.
Detainees may arrive in police custody having left a prison only hours 
previously. Details of the clinical management of a drug or alcohol problem 
may be sought from the healthcare department of the prison. It is worth 
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noting that all controlled drugs are routinely taken under supervised 
conditions in all prisons. A criminal justice integrated team from a 
detainee’s home area will also hold information on drug services received 
by their clients in prison. This is valuable in the context of continuation of 
prescribed medical management (see Section 3.11).
3.7 Drug treatment monitoring systems
In England, the National Drug Treatment Monitoring System (NDTMS) 
collects, collates and analyses information from, and for, those involved 
in the drug treatment sector. The NDTMS is a development of the system 
that previously involved the Regional Drug Misuse Databases (RDMDs), 
which had been in place since the late 1980s. Responsibility for the 
NDTMS in England and Wales lies with the National Treatment Agency 
for Substance Misuse. The data are submitted by treatment providers by 
electronic data transfer, and there is no need for forensic physicians to 
submit data.
For Northern Ireland, the Northern Ireland Drug Misuse Database 
(NIDMD) is the system used to collect treatment attendance data. In 
Scotland, the equivalent system is the Scottish Drug Misuse Database 
(SDMD). Neither database requires completion by forensic physicians.
3.8 Statutory notification of addicts
Doctors in Great Britain are no longer required to notify cases of addiction 
to chief medical officers. However, the statutory requirement to report cases 
of addiction still applies in Northern Ireland.
The Misuse of Drugs (Notification of and Supply to Addicts) (Northern 
Ireland) Regulations 1973 require all doctors, including forensic physicians, 
to notify the Chief Medical Officer of the Department of Health, Social 
Services and Personal Safety in writing within 7 days if they attend a patient 
whom they consider to be, or have grounds to suspect is, addicted to any 
of the following controlled drugs: cocaine, methadone, dextromoramide, 
morphine, diamorphine (heroin), opium, dipipanone, oxycodone, 
hydrocodone, pethidine, hydromorphone, pentazocine, levorphanol and 
piritramide. Failure to notify within 7 days can result in disciplinary action 
against the doctor. Although notification does not imply that a prescription 
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for a controlled drug has been, or will be, given by the doctor, where this 
is the case full details should be supplied.
The following information must be supplied on the notification: 
patient’s name, address, gender, date of birth, health service number if 
known, the date of attendance and name of the drug or drugs concerned. 
All notifications should be sent to the Medical Officer at the Department 
of Health, Social Services and Public Safety (Medical Officer, C3.15 Castle 
Buildings, Belfast BT4 3SQ. Tel.: 028 9052 2421).
3.9 Arrest referral schemes and Drug Interventions Programme
Since April 2002, all police custody suites have had arrest referral or drug 
referral schemes. These schemes are partnership initiatives between the 
police, local agencies and drug action teams that aim to reduce drug-related 
crime by encouraging problem drug users who are arrested to take up 
appropriate treatment or other programmes of help. Involvement with the 
scheme is voluntary on the part of the arrestee.
In 2004, the Criminal Justice Interventions Programme, now known as 
the Drug Interventions Programme, was introduced as a critical part of the 
government’s strategy for tackling drugs. It aims to direct drug-misusing 
offenders out of crime and into treatment through criminal justice and 
treatment agencies working together with other services. It draws together 
and builds on the best existing solutions, such as arrest referral, and 
introduces new elements. Delivery at a local level is through integrated 
teams using a case management approach to offer access to treatment and 
support. This begins at an offender’s first point of contact with the criminal 
justice system and continues through custody, court, sentence and beyond, 
into resettlement.
Work in the custody suite, soon after arrest, is a crucial entry point into 
this overall programme. Arrest referral or Drug Interventions Programme 
workers seek to engage drug-using arrestees with the aim of providing 
information and, where appropriate, providing (or referring them on for) 
treatment or other means of assistance.
A range of offences now ‘trigger’ drug testing of offenders on arrest. 
This is another way of identifying problem drug users at an early stage of 
their contact with the criminal justice system. Research has linked all of the 
trigger offences to drug-related offending. The screening test is limited to 
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looking for evidence of the presence of heroin, cocaine and crack cocaine. 
It is an accurate and non-intimate test that normally involves a swab under 
the tongue, is completed in minutes and provides results immediately. The 
results of the tests can lead to prompt referrals for treatment and are also 
used to inform court decisions on bail and sentencing. All of those testing 
positive should be given the opportunity to see an arrest referral worker, 
even if they have declined any previous offer. Disputed tests are referred 
to forensic science service providers for confirmatory laboratory analysis.
Forensic physicians should be aware of test results where available, as 
these may assist in the overall assessment of a detainee. The time limit for 
a positive test result in an oral fluid sample is 24–48 hours. 
Forensic physicians are in a position to encourage detainees, especially 
those who have tested positive, to make the best use of the arrest referral 
services. They might also refer an individual, with their consent, to the 
arrest referral worker if they identify a substance misuse issue. All custody 
suites should have information about arrest referral and Drug Interventions 
Programmes, and forensic physicians should be familiar with this.
Further information about the Drug Interventions Programme is 
available at www.homeoffice.gov.uk/crime/reducing-reoffending/dip.
3.10 Medical complications of substance misuse and reducing 
the health risks
Many substance misusers have little or no contact with doctors or other 
healthcare professionals and therefore chronic conditions such as diabetes, 
heart disease and asthma are poorly managed. It is essential that forensic 
physicians encourage detainees to see their general practitioner or attend 
hospital clinics to receive the appropriate care for long-term conditions. 
Substance misuse may result in medical complications that require 
assessment and further treatment. 
Infective endocarditis, superficial thrombophlebitis, deep vein 
thrombosis, pulmonary embolus, and chronic complications of limb 
swelling and venous ulcers may result from intravenous drug use. 
If an injection occurs into an artery, vascular spasm may result in 
ischaemia and eventually, if prompt treatment is not provided, gangrene 
and amputation. 
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Cellulitis and abscesses may be seen around injection sites, and septic 
arthritis may result if deep abscesses extend into joints. 
Many substance misusers suffer from self-neglect: malnutrition and 
dental decay may be present, as may infectious diseases such as hepatitis 
B, C, HIV and AIDS.
It is essential that forensic physicians provide treatment where necessary, 
referring to hospital as appropriate. 
A visit by a forensic physician or other healthcare professional provides 
an opportunity to advise the detainee on risk reduction in relation to 
continued substance misuse. Although they are not always possible, 
strategies that can be usefully employed during this consultation include:
 referral to an on-site arrest referral/drug worker
 information about local agencies involved in counselling and treatment 
of substance-related problems, such as community drug and alcohol 
teams, treatment centres and needle exchange schemes
 special attention given to sexual health issues, particularly those 
associated with prostitution, enabling access to emergency contraception 
where required, and providing advice with regard to screening and 
further treatment for sexually transmitted diseases
 general awareness of blood-borne viruses (hepatitis B and C and HIV) 
and guidance on the availability of hepatitis B vaccination and of the 
risk to themselves and to close family members
 education on the hazards of injecting drugs, particularly with regard to 
shared injecting equipment
 education on the risks of overdose, of multiple substance misuse, 
including alcohol, and of the variable purity of illicit drugs
 advice regarding the loss of tolerance and risk of fatality following 
reduction in regular use or a period of abstinence such as may occur 
following time in prison (where detoxification is the chosen treatment 
option) or residential rehabilitation.
A significant minority of injecting drug users have experienced a broken 
needle at some time in their injecting career (Norfolk & Gray, 2003). 
Central embolisation may occur in a few hours to several days and can 
have potentially fatal consequences such as pericarditis, endocarditis and 
pulmonary abscess. It is recommended that needle fragments be removed 
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as soon as possible to avoid future complications. This will necessitate 
attendance at an emergency (A&E) department.
3.11 Prescribing
Substance misuse, even with some degree of dependence, is not in itself 
an indication for prescribing a substitute drug if the time in custody is 
brief. Simple reassurance or the prescription of symptomatic drugs may be 
helpful and effective in alleviating the detainee’s anxiety about withdrawal, 
and in limiting the emergence of withdrawal symptoms. Decisions about 
prescribing will need to consider not only the clinical presentation but also 
the anticipated length of time in custody and whether or not the individual 
will be returning to the community or is likely to be sent to prison.
Forensic physicians may have access to certain medication in police 
stations with an agreed formulary or may carry their own supplies. 
Arrangements will vary as to how medication is obtained and it is important 
that forensic physicians are aware of local procedures. 
3.11.1 Consideration of prescribing/authorising continuation of substitute drugs
It cannot be stressed too strongly that a comprehensive clinical examination 
(which includes the taking of a history and the keeping of accurate notes) 
should be carried out to assess the objective signs of withdrawal and to 
correlate these with the subjective symptoms complained of by the detainee.
Documentation of basic parameters such as pulse, blood pressure and 
size of pupils are essential and particularly useful when a reassessment is 
performed by the same doctor or a colleague. Information for colleagues 
should be left in a confidential, sealed envelope.
Care must be taken to exclude the presence of intoxication by 
substances and/or alcohol (including legitimately prescribed drugs such 
as benzodiazepines).
Information from other sources, including the prescriber (general 
practitioner, drug-dependency clinic or voluntary agency) and dispenser 
(pharmacist or voluntary agency), should be obtained if possible. 
The enquiry should include details of medication prescribed, dosage, 
duration of treatment and recent urine screening results. If methadone, 
buprenorphine or, indeed, any other medication is being supervised daily 
at a pharmacy or clinic, the level of dependence on the prescribed dose 
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cannot automatically be assumed. There may have been missed doses, 
concealment (buprenorphine) or regurgitation (methadone) if the dose 
was not properly supervised, and/or a time lag since the last supervised 
dose because of a weekend. The detainee may, of course, be continuing to 
use illicit substances as well. 
National Health Service prescriptions must not be issued for individuals 
detained in police custody (Home Office Circular 17/1950) unless the 
service is provided by the NHS (as, for example, in Lothian & Borders); 
drugs should be prescribed on a private prescription paid by the police. 
For Schedule 2 and 3 controlled drugs, forensic physicians should use 
the private prescription FP10PCD (England), WP10PCD (Wales), PCD1 
(Northern Ireland) or PPCD91 (Scotland). Generally, all medication in 
the police station is held by the custody officer on behalf of the detainee 
and should be kept in a locked receptacle to prevent unauthorised access.
3.11.2 Near-patient testing
The use of an on-site drug-testing kit in the police station may be helpful 
in police custody (Stark et al, 2002). Such tests give qualitative rather than 
quantitative results and so confirm whether or not a substance has been used 
rather than the quantity of the substance used. Doctors should ensure that 
they are familiar with the test employed and with its limitations, including 
false positives and false negatives. The test should only be used with the 
consent of the detainee and with the clear understanding that this is an 
aid to clinical management and it will remain part of the clinical record. 
Cross-reactivity occurs with codeine products, among other compounds, 
but not methadone or buprenorphine.
3.11.3 Assessment procedure
The following steps are recommended:
(1) On an initial assessment, especially if the detainee is seen soon after 
arrest, it would be unusual to prescribe any drugs immediately. This 
cautious approach is taken because the detainee may have recently 
taken substances, the full effects of which may not yet be obvious. 2
(2) If there is evidence of intoxication, NO substitution treatment should be given 
until the intoxication has resolved and withdrawal signs are manifest. Many 
substances, for example methadone with alcohol, have an additive 
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effect leading to significant morbidity or mortality. Consideration of 
whether the detainee is fit for detention is then the priority.
(3) It should be remembered that most individuals are not detained in 
police custody for very long and that medical treatment in the form 
of substitute drugs may therefore not be required. However, for 
those detained for longer periods, previously prescribed substitution 
treatment should be continued, if in the forensic physician’s judgement 
it is safe to do so.
(4) The forensic physician should recommend reassessment after a 
specific period depending on the history given by the detainee and 
the examination findings. Reassessment of a heroin user, for example, 
may be helpful after 8 hours, as heroin has a short half-life compared 
with methadone. Reassessment must be by a healthcare professional 
with appropriate expertise and the ability to prescribe or administer 
under a patient group direction (PGD) any medication identified as 
necessary.
(5) In the absence of withdrawal signs, confirmation of opioid substitution 
treatment should be sought from other reliable sources before 
authorising continuation of treatment.
(6) The prescribed dose of opioid substitution treatment does not 
necessarily accurately indicate actual consumption, as part of or the 
entire dose may be given to other individuals. Therefore, the doctor 
needs to know not only the amount prescribed but also whether the 
detainee is actually taking the drug. 
(7) It should be remembered that even a small amount of opioids may be fatal to 
a non-dependent individual. 
(8) The decision to prescribe opioid substitution treatment and supervise 
self-administration is the responsibility of the forensic physician, even 
when the drug is collected from the usual clinic or pharmacist.
(9) If there is doubt about the daily dose, then the dose can be divided 
and given every 6–12 hours.
(10) Any forensic physician can prescribe substitution drugs (except for 
diamorphine, dipipanone and cocaine) for the treatment of depend-
ence, and it may be more convenient to arrange for the prescription 
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to be dispensed at a local pharmacy. However, the regular prescribing 
doctor and the pharmacist or clinic responsible for dispensing should 
be informed, to avoid duplicate dispensing, should the detainee be 
released from custody earlier than previously anticipated.
(11) It should be remembered that if a single dose is prescribed and 
given by the forensic physician, a detainee may not be able to pick up 
subsequent days’ doses from the pharmacy on release from detention. 
This will depend on how their regular prescription has been written. 
For example, if the individual has to collect their prescription twice 
weekly, unless the prescriber has appended wording that allows 
the balance to be supplied if the patient misses the collection day, 
the pharmacist cannot supply a missed instalment on a subsequent 
collection day. Therefore, the forensic physician should check with 
the pharmacy when the individual can collect their next dose and, if 
necessary, write a new script to cover any missed instalments or liaise 
with the original prescriber to ensure continuation of therapy.
(12) If the detainee is not under current treatment or treatment details 
cannot be verified but he or she nevertheless has a clear history, signs 
of regular drug use and objective evidence of withdrawal symptoms 
and signs, then treatment should be given to alleviate the withdrawal 
syndrome.
(13) Forensic physicians should prescribe substitution treatment only if 
they are sure that it is clinically safe to do so. Even if the doctor is 
confident and has objective evidence of dependence on prescribed 
drugs, the doctor should still advise the detainee and the police of 
the possible side-effects of intoxication as a matter of good practice.
3.11.4 Administration of medication in police stations
The PACE Code of Practice for the detention, treatment and questioning of 
persons by police officers (Code C) gives guidance on the administration 
of medication (Home Office, 2006). This legislation applies to England, 
Wales and Northern Ireland. Paragraph 9.9 of the Code states:
‘If a detainee is required to take or apply any medication in compliance with 
clinical directions prescribed before their detention, the custody officer 
must consult the appropriate healthcare professional before the use of the 
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medication. […] The custody officer is responsible for the safekeeping of any 
medication and for making sure that the detainee is given the opportunity 
to take or apply prescribed or approved medication.’
Paragraph 9.10 of the Code gives guidance in relation to controlled 
drugs, stating:
‘No police officer may administer or supervise the self-administration 
of controlled drugs of the types and forms listed in the Misuse of Drugs 
Regulations 2001, Schedule 1, 2 or 3. A detainee may only self-administer 
such drugs under the personal supervision of the registered medical 
practitioner authorising their use.’ 
This includes, for example, methadone oral solution, buprenorphine, 
methylphenidate, phenobarbitone and temazepam.
The custody officer can distribute drugs listed in Schedule 4 (e.g. 
diazepam) or 5 (e.g. dihydrocodeine) for self-administration if they have 
consulted the registered medical practitioner authorising their use. This 
may be done by telephone. It is essential that the medication is checked as 
belonging to the detainee and that the details on the label match the con-
tents. Both parties must be satisfied that self-administration will not expose 
the detainee, police officer or anyone else to the risk of harm or injury.
It remains good practice to advise police staff that, if they have any 
concerns regarding the drug to be administered, they should have no 
hesitation in telephoning the forensic physician to discuss those concerns 
and whether a visit is required.
The police should ensure that the treatment recommended by the 
doctor is properly administered by the detainee and documented and that 
all ingestion of medication is supervised (Faculty of Forensic and Legal 
Medicine, 2011).
No police officer should measure out doses of methadone or any other 
medicines.
Intravenous medication for treatment of substance misuse is generally 
inappropriate in this setting and should be avoided. If opioid substitution 
treatment is required, oral formulations should be given. There is no 
recognised indication for prescribing amphetamines, cocaine or injectable 
benzodiazepines for the treatment of dependence in police custody.
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4 Fitness for interview
4.1 General considerations
An opinion may be requested as to the detainee’s fitness for interview. The 
doctor should ask the custody officer the probable period of detention 
and the likelihood and timing of any proposed interview. Withdrawal or 
intoxication may affect a detainee’s fitness to be interviewed, and symptoms 
and signs may vary with time. Consequently, the finding of fitness for 
interview is potentially time-limited. Forensic physicians should ensure 
that an accurate record is made of the examination conducted, including 
the reasoning behind their decision as to whether the detainee is fit or 
unfit for interview.
4.2 Definition (Annex G of PACE Codes of Practice Code C)
‘A detainee may be at risk in [a police] interview if it is considered that:
(a) conducting the interview could significantly harm the detainee’s 
physical or mental state;
(b) anything the detainee says in the interview about their involvement 
or suspected involvement in the offence about which they are being 
interviewed might be considered unreliable in subsequent court 
proceedings because of their physical or mental state.’ 
(Home Office, 2011: Code C, Annex G)
When forensic physicians identify risks, they should attempt to quantify 
the risk. They should also inform the custody officer:
 whether the person’s condition is likely to improve 
 whether the condition requires or is amenable to treatment 
 how long it may take for any improvement to take effect.
In assessing whether a detainee should be interviewed, the following must 
be considered:
(a) how the detainee’s physical or mental state might affect their ability to 
understand the nature and purpose of the interview, to comprehend 
what is being asked and to appreciate the significance of any answers 
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given and make rational decisions about whether they want to say 
anything;
(b) the extent to which the detainee’s replies may be affected by their 
physical or mental condition rather than representing a rational and 
accurate explanation of their involvement in the offence;
(c) how the nature of the interview, which could include particularly 
probing questions, might affect the detainee. 
Therefore, the forensic physician must consider the various vulnerability 
factors that render an individual more likely to provide an unreliable 
confession. These factors include the health of the individual (physical 
and mental, including substance misuse), the likely demand characteristics 
of the interview, personality traits that increase vulnerability, and the 
totality of the circumstances (personality/health/interview/totality of the 
circumstances: PHIT) (Norfolk, 2001).
The definition of fitness for interview is distinct from the definition 
of fitness to plead.2 Forensic physicians should be aware that the risk of 
unreliability with regard to substance misusers may vary; for example, 
there may be a major risk, with severe intoxication or withdrawal, where 
the detainee will be unfit for interview and reassessment may be considered 
necessary to establish fitness at a later stage.
Alternatively, there may only be some risk of unreliability, where certain 
precautions may be advised, such as the presence of an appropriate adult 
for a detainee who has mental health and substance use problems and/
or learning disabilities. Alcohol- or drug-related memory deficit may 
also produce temporary or permanent (for example, Korsakoff states) 
impairment of fitness for interview.
4.3 False confessions
Forensic physicians need to be aware of the various types of false confession, 
as the doctor’s primary concern is to recognise any characteristics that 
might render the individual vulnerable to providing a false confession, so 
that adequate safeguards can be put in place.
2. In assessing fitness to plead, medical witnesses are asked whether the accused 
has capacity to instruct his or her lawyer, to plead to the charge, to challenge a 
juror and to understand the evidence (see Chiswick, 1990: p. 174).
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Suggestibility and compliance have been shown to be relevant to the 
issue of false confessions; however, their assessment is best performed by 
clinical psychologists.
False confessions have been divided into voluntary, coerced–compliant, 
coerced– internalised (Kassin & Wrightsman, 1985) and accommodating–
compliant (Wolchover & Heaton-Armstrong, 1996: p. 99).
A voluntary false confession is made without any external pressure 
from the police and may occur for a number of reasons, such as a morbid 
desire for notoriety.
An accommodating–compliant false confession is made by people for 
whom acquiescing with the police is more important than contradicting 
police assertions about what has happened. In such circumstances, a false 
confession is borne out of a strong need for approval and to be liked.
A coerced–compliant false confession results from the pressure of 
the police interview or custody. The suspect gives in to the demands 
and pressure of the interviewers for some immediate gain, such as being 
allowed to go home. The suspect may be preoccupied with escape from 
a stressful situation, while giving little attention to the potentially serious 
long-term implications of making a false confession. Addicts are at risk 
of this type of false confession, where they are fully aware of not having 
committed the crime, but will confess in an attempt to escape from an 
intolerable situation.
A coerced–internalised false confession happens when the suspect 
comes to believe, at least temporarily, that they may have committed the 
crime that they are accused of. Suspects may do this even though they have 
no actual memory of committing the crime. A history of alcohol and drug 
misuse may lead to a coerced–internalised false confession, where people 
come to distrust their own memory or have frank memory impairment 
(temporary or permanent) and are suggestible to external cues. Comorbid 
severe mental illness can also lead to this type of confession.
4.4 The possible impact of substance misuse withdrawal states 
on the validity of a confession
4.4.1 Vulnerability factors
Many confessions given in withdrawal states are reliable, and later attempts 
at retraction, coupled often with allegations of police malpractice, are 
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properly dismissed by judge and jury. However, a person who is suffering 
from alcohol or drug withdrawal must be seen in some ways as especially 
vulnerable to giving a false confession.
Forensic physicians should be aware of possible vulnerability factors. 
Detainees often believe that compliance will result in early release and 
charges being dropped or altered, and that stubbornness, on the other 
hand, will lead to further detention. There may be certain factors about 
which the doctor can do something, for example offering brief intervention/
counselling or reassurance that if detained for any length of time in the 
police station, there will be access to a doctor who can provide effective 
treatment to alleviate withdrawal symptoms.
It should be noted that drug withdrawal states may markedly affect levels 
of anxiety and prevailing mood, which in turn may affect the detainee’s 
performance.
In assessing the likely impact of any vulnerability factors on a detainee’s 
fitness for interview, the doctor needs to consider the likely demand 
characteristics of the interview, as the perceived seriousness of the alleged 
offence seems to be the most important factor in determining how well a 
person will withstand the demands of an interrogation.
Although the police service is actively supporting the operation of 
arrest referral schemes, it is still important to recognise that an admission 
by a detainee to being a drug addict perhaps invites the obvious line of 
questioning by police officers as to how the individual finances their habit. 
Furthermore, any admission of involvement with an illicit market may later 
be brought up by the prosecution when cross-examining the accused in 
court, and the jury may well regard addiction as a taint, bearing directly 
and negatively on credibility. Thus, the very fact of being an addict may in 
itself add a further element of vulnerability.
4.4.2 The general impact of withdrawal on the mental and physical state of the 
accused
Individuals who are undergoing questioning are engaged essentially in 
an adversarial encounter, in which they are trying to retain coherence of 
their story and the integrity of their defence, particularly when questioning 
is carried out by people who are skilled in interview techniques. It is self-
evident that the physical and mental distress occasioned by substance 
withdrawal may, at times, handicap a person who is subjected to this rather 
threatening and difficult experience.
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4.4.3 Forensic physicians and the prescription of drugs to allay withdrawal
Forensic physicians deciding on prescribing must at times be influenced by 
an awareness that if the accused person is interviewed after having been 
given therapeutic drugs, it may later be argued that the treatment itself 
had a bearing on fitness to undergo questioning and the admissibility of 
a confession. Continuing substitution therapy in police custody that the 
detainee has been receiving in the community is unlikely to influence 
fitness for interview. However, when substitution therapy is initiated in 
custody, or when symptomatic treatment alone is provided, the doctor 
may well need to assess the impact of the treatment before an interview 
takes place.
Symptoms and signs of mild opioid withdrawal may be no barrier to 
interview, whereas severe withdrawal may render an addict unfit to be 
interviewed until the peak of withdrawal subsides after 2–3 days or is 
brought under control with opioid substitution treatment.
The Court of Appeal (Criminal Division) has ruled that the mere fact 
that an addict is withdrawing and might have a motive for confession does 
not necessarily make the confession unreliable (R. v. Crampton Court of 
Appeal [Criminal Division], 1990). Whether an addict is fit to be interviewed 
in the sense that his or her answers can be relied on as being true is a 
matter for those present at the time. Considerable weight is likely to be 
given to the medical evidence. However, the admissibility of any statement 
will be decided in court by the judge and its credibility by the jury.
Withdrawal from alcohol and other sedative/hypnotic drugs can be very 
severe and distressing, with a risk of delirium tremens and convulsions. 
Fitness to be interviewed may be seriously impaired and the detainee may 
first need to be stabilised on sedative medication, preferably a long-acting 
drug such as diazepam. The mental state may then need re-examination to 
assess the individual’s fitness for interview. Polysubstance misuse, which is 
increasingly common, will complicate matters further, particularly where 
both drugs and alcohol have been taken.
When the detainee is considered fit to be interviewed, the forensic 
physician should, where possible, provide the custody officer with an 
estimate of how long the fitness is likely to last. In some cases, particularly 
with long interviews, the doctor may consider it prudent to recommend 
re-examination following the interview.
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4.5 The possible effect of substance misuse intoxication on the 
validity of a confession
In practice, a problem due directly to intoxication probably arises less often 
than issues relating to withdrawal. If an individual is obviously drunk or 
drugged when brought into the police station, the police will usually wait 
until the intoxication has cleared before commencing questioning.
However, hallucinogenic substances may give rise to difficulties in 
this respect. For example, the mental state may fluctuate in the recovery 
stages of a lysergic acid diethylamide (LSD) experience and, although the 
apprehension and distraction that this causes may not be immediately 
evident to onlookers, it may have a bearing on suggestibility and resistance 
to questioning. Forensic physicians should be aware of this possibility and 
be prepared to advise the police accordingly.
Intoxication may present with subtle effects of drug use not amounting 
to obvious impairment of consciousness. For example, benzodiazepines 
may have an effect on short-term recall, vigilance and self-monitoring; 
stimulants may have effects on aggression and inhibition; and cannabis on 
memory, perception and concentration. If there is doubt, then reassessment 
is recommended after an appropriate interval.
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5 Managing specific drug problems (Ghodse, 2010)
The increasing likelihood of polysubstance misuse and associated problems, 
such as drug interactions and dependence on different classes of drug, 
should be borne in mind when considering the management of each 
individual detainee.
There should be a high level of awareness of alcohol problems when 
assessing substance misusers, and a high level of suspicion of organic 
disorder.
Female detainees should be asked about the possibility of pregnancy, as 
this may influence the choice of treatment (see Section 3.3.1).
Treatment of younger detainees by substitution or symptomatic 
medication should be undertaken with great caution (Department of 
Health, 2009). Younger people are less likely to be dependent and are 
more likely to suffer adverse effects to medicines used more commonly in 
adult patients.
Great caution should be exercised in the medication of elderly patients 
who present with alcohol and/or opioid dependency or dependency on 
prescribed drugs. Doses of medication required for symptomatic relief are 
usually less than in adult patients. There is also a greater likelihood of an 
underlying organic problem.
Once dependence has been diagnosed, sufficient treatment should 
be provided for the proposed period of detention. There should be a low 
threshold for frequent medical reviews in the early stages of treatment.
5.1 Alcohol
5.1.1 Symptoms and signs of intoxication
Alcohol acts as a central nervous system (CNS) depressant. In small doses 
it affects cortical function but in larger doses may depress medullary 
function. The clinical effects of alcohol vary considerably between different 
individuals, depending on their degree of tolerance.
Alcohol intoxication may result in nystagmus; normal or dilated pupils 
(although as the level of intoxication increases and coma results, the pupils 
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often become pin-point); slurred speech; increase in blood pressure and 
pulse with moderate doses; incoordination and ataxia.
Care should be taken to exclude concurrent medical problems in alcohol-
intoxicated detainees, in particular head injuries and hypoglycaemia, which 
may complicate the picture.
An intoximeter may be a valuable tool to assess the blood alcohol 
concentration and facilitate diagnosis and treatment, but any decision 
regarding whether a suspect who has been drinking alcohol is fit for 
interview is best made on a full assessment, rather than on arbitrarily 
defined ‘safe’ blood alcohol levels (Rogers et al, 1995).
5.1.2 Symptoms and signs of withdrawal
In alcohol-dependent individuals, withdrawal symptoms may begin 6–8 
hours after the last consumption of alcohol and before the blood alcohol 
level reaches zero. It should always be remembered that alcohol use may 
not be disclosed and that alcohol withdrawal may mimic other withdrawal 
syndromes.
5.1.3 Treatment of withdrawal
Withdrawal from alcohol in police custody can pose a serious threat to 
the individual’s health. An attempt should be made to assess the degree 
of dependence and initiate early treatment to avoid the complications of 
withdrawal, such as convulsions and delirium tremens.
Benzodiazepines, for example chlordiazepoxide or diazepam, are the 
treatments of choice (Mayo-Smith, 1997). If the detainee is unable to take 
oral medication, transfer to a general hospital for parenteral treatment 
should be arranged.
5.2 Benzodiazepines
5.2.1 Symptoms and signs of intoxication
Benzodiazepine intoxication presents with inattentiveness, reduced muscle 
tone and poor coordination, impaired recall and eventually disorientation 
and drowsiness. Large doses may be consumed without producing 
drowsiness in the presence of tolerance, although effects on anxiety and 
memory may still be significant.
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Table 5.1 Benzodiazepine withdrawal syndrome
Anxiety symptoms Disordered perceptions Major complications
Anxiety Feelings of unreality Psychosis 
Sweating Abnormal body sensations Epileptiform seizures
Insomnia Abnormal sensation of movement
Headache Hypersensitivity to stimuli
Tremor
Nausea
5.2.2 Symptoms and signs of withdrawal
Sudden cessation of benzodiazepines in dependent individuals can lead to 
a recognised withdrawal state, including delirium and seizures in severe 
cases (Table 5.1).
The withdrawal syndrome usually develops within 2 days, but the risk 
of seizures during short-term detention is low.
In recent years, the regular misuse of very large amounts of benzo-
diazepines, orally or intravenously, has been more prevalent, especially 
in combination with opioid and/or alcohol misuse. There are marked 
similarities to alcohol withdrawal symptoms and signs, and careful history-
taking and examination are required.
Clonazepam is a second-line treatment for epilepsy (e.g. National 
Collaborating Centre for Primary Care, 2004), and detainees may say that 
they are receiving the drug for this purpose. If possible, the diagnosis of 
epilepsy should be confirmed before prescribing further clonazepam.
5.2.3 Treatment of withdrawal
Once intoxication has been excluded, benzodiazepine withdrawal can be 
treated. Treatment is aimed at alleviating symptoms and preventing the 
major complications of fits and psychosis.
Although any benzodiazepine will control the withdrawal syndrome, 
a long-acting one is preferable. Diazepam has several advantages because 
of its relatively long half-life and availability in many different strengths of 
tablet. A dose of diazepam 10 mg three times a day should be adequate to 
prevent withdrawal seizures, but may need to be titrated upwards to prevent 
withdrawal symptoms and signs (Table 5.2). 
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Table 5.2 Appropriate dosages of common benzodiazepines and Z-drugs 
equivalent to 5 mg diazepam
Drug Dose
Chlordiazepoxide 15 mg 
Diazepam 5 mg 
Loprazolam 0.5 mg 
Lorazepam 0.5 mg 
Oxazepam 15 mg 
Temazepam 10 mg 
Nitrazepam 5 mg
Zaleplon 10 mg
Zopiclone 7.5 mg
Zolpidem 10 mg
An anti-epileptic drug should be considered only if the individual is 
already receiving such drugs, or if there is a past history of seizures due to 
epilepsy or a structural brain lesion.
5.3 Opioids
5.3.1 Symptoms and signs of intoxication
Intoxication with opioids causes a feeling of well-being. Those under their 
influence may display a euphoric appearance. At times they may appear 
slightly distant, drowsy or unable to concentrate.
Pin-point or small pupils are a good clinical indication of recent opioid 
use.
Intoxication with opioids can lead to hypotension, bradycardia, cyanosis, 
respiratory depression, loss of consciousness and death. Onset may be 
rapid with parenteral use and delayed several hours with oral use. Close 
observation and provision of respiratory support are essential, especially 
when the respiratory rate is slow or irregular. Oxygen should be used if 
available in suspected cases of opioid overdose. 
Naloxone is an opioid antagonist which can be used to reverse the effects 
of severe opioid intoxication. Rapid reversal of opioid effects may precipitate 
an abrupt withdrawal syndrome. Where severe opioid intoxication is 
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suspected, an emergency ambulance must be called immediately and 
naloxone given in an initial dose of 0.4–0.8 mg intravenously or intra-
muscularly. If there is no response after 2–3 minutes, the dose should 
be repeated. If there is no response after further doses (to a maximum 
of 10 mg), the diagnosis is in question and other conditions, for example 
hypoglycaemia, should be considered.
5.3.2 Symptoms and signs of withdrawal
The severity of opioid withdrawal symptoms is influenced greatly by 
psychological factors. The environment in a police cell is likely to exacerbate 
these symptoms. Observable or measurable signs of opioid withdrawal 
include those shown in Table 5.3.
The start of withdrawal symptoms will vary with different opioid drugs. 
On average, the symptoms of heroin withdrawal start within 8 hours, 
progress to a peak and then gradually improve within 48–72 hours.
The severity of withdrawal symptoms is not directly related to the 
quantity of drugs previously consumed.
Withdrawal from methadone usually leads to a less severe but more 
protracted abstinence syndrome than withdrawal from heroin. When 
assessing the severity of withdrawal, greater weight should be given to 
observable signs than to subjective symptoms.
Table 5.3 Symptoms and signs of opioid withdrawal
Symptoms Signs
Sweating Dilated pupils 
Lachrymation and rhinorrhoea Goose flesh 
Yawning Flushing 
Feeling hot and cold Sweating 
Anorexia and abdominal cramps Running nose and eyes
Nausea, vomiting and diarrhoea Tachycardia, hypertension
Tremor Increased bowel sounds
Restlessness and insomnia
Anxiety, agitation 
Generalised aches and weakness
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5.3.3 Symptomatic treatment of withdrawal
It is essential that treating forensic physicians take time to allay any anxiety 
detainees have about the treatment provided in police custody. 
Symptomatic relief of withdrawal symptoms (Table 5.4) can be achieved 
in the short term without substitution of the drug of dependence. However, 
for those who are likely to remain in custody (including prison) for a longer 
period, symptomatic treatment is not as effective as substitution treatment.
The routine use of benzodiazepines for anything other than 
benzodiazepine or alcohol dependence is not to be recommended in 
Table 5.4 Symptomatic treatment of opiate withdrawal
Symptom Drug Administration
Vomiting Buccal 
prochlorperazine
3 or 6 mg (one or two 3 mg tablets) absorbed 
from buccal cavity twice daily. Useful if unable 
to retain oral medication.
Metoclopramide 10 mg three times daily. Not known to be 
harmful in pregnancy. Action antagonised by 
opioid analgesics.
Abdominal 
cramps
Mebeverine 135 mg three times daily, preferably 20 minutes 
before meals. Antispasmodic, not known to be 
harmful in pregnancy. 
Diarrhoea Loperamide 4 mg initially, followed by one after each loose 
stool; maximum 16 mg daily. An opiate receptor 
agonist which acts on the gut to reduce 
peristalsis, increase intestinal transit time and 
increase the tone of the anal sphincter. 
Minor aches 
and pains
Paracetamol or 
NSAID such as 
ibuprofen
Paracetamol: 1 g up to four times daily. Not 
known to be harmful in pregnancy.
Ibuprofen: initially 200–400 mg three or four 
times daily; maximum 2.4 g daily. Avoid NSAIDs 
in pregnancy, especially in the third trimester.
Insomnia Zopiclone 7.5 mg at night. Elderly: initially 3.75 mg 
at night, increased if necessary. Non-
benzodiazepine acting at the benzodiazepine 
receptor, with lower incidence of dependency 
than benzodiazepines. Short duration of action 
so less likelihood of ‘hangover’ effect.
NSAID, non-steroidal anti-inflammatory drug.
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police custody as such drugs may affect cognition and therefore fitness to 
be interviewed. Furthermore, if the detainee is subsequently transferred 
to prison he or she may claim to be dependent on benzodiazepines and, as 
these drugs will appear in the initial urine drug screen test on reception, 
this may result in a long, slow period of unnecessary detoxification. 
5.3.3.1 Lofexidine
Lofexidine is not normally initiated in police custody but it should be 
continued if previously prescribed.
This is a non-opioid drug, an alpha-adrenergic agonist, which counter-
acts most of the symptoms of opioid withdrawal if given in adequate doses 
(e.g. 0.2–0.4 mg, 4–6 hourly). It is authorised for the management of 
opioid withdrawal (Department of Health (England) and the devolved 
administrations, 2007) and may be considered for those who have decided 
not to use methadone or buprenorphine for detoxification, have decided 
to detoxify within a short period of time, or have mild or uncertain 
dependence (including young people) (National Collaborating Centre 
for Mental Health, 2007). Lofexidine has potential adverse effects on the 
cardiovascular system (hypotension and bradycardia). Physical examination 
(including measurement of blood pressure and pulse) is therefore required 
before starting treatment and should be repeated regularly during 
treatment in police custody. 
5.3.4 Use of substitute opioids
Mild opioid withdrawal can be controlled by symptomatic medications, as 
described above. There will be cases of marked withdrawal not managed 
by symptomatic medication, where opioid drugs may be required to control 
the symptoms and signs.
Caution should be exercised when prescribing opioid substitution 
treatment in the absence of withdrawal signs or other confirmatory 
information and confidence about previous consumption. Either liquid 
oral preparations (e.g. methadone oral solution 1 mg/ml) or codeine-based 
tablets are preferred. Opioid equivalents to 1 mg methadone are shown in 
Table 5.5.
‘Street’ heroin varies in purity and consumption cannot be accurately 
estimated. Therefore, the dose should be titrated against withdrawal 
symptoms and signs, starting, for example, with methadone 10 mg and 
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reviewing later to see whether withdrawal symptoms and signs have 
subsided. It is essential that an initial low dose is used and NOT more than thirty 
milligrams (30 mg) of methadone in 24 hours in divided doses or equivalent should 
be prescribed. Hospital admission may be required in certain circumstances.
5.3.5 Choosing substitute drugs
Preventive prescribing on the assumption that someone is dependent is 
not safe practice and should not be done unless the forensic physician is 
confident that a detainee is dependent.
Table 5.5 Opioid equivalents for withdrawal: related potencies for 
withdrawal protocols equivalent of 1 mg methadonea
Drug Dose
Codeine 15 mg 
Dextromoramide 0.5–1 mg 
Dextropropoxyphene 15–20 mg 
Dihydrocodeine 10 mg 
Dipipanone (Diconal®) 2 mg 
Pharmaceutical heroin 1–2 mg
Hydromorphone  0.5 mg 
Methadone linctus 1 mg/2.5 ml 
Methadone oral solution 1 mg/ml
Morphine 3 mg 
Pethidine 15 mg 
Buprenorphineb 0.04 mg 
Pentazocineb 10 mg 
Gee’s linctus® 10 ml (1.6 mg of morphine) 
J Collis Browne’s mixture® 10 ml (1 mg extract of opium)
a. This table can be used to convert the dose of other opioids into milligrams of methadone but, 
owing to the different half-life of other drugs and their mode of administration, the conversion 
can only be a guide. Whichever drug of substitution is used, the dose should be titrated against 
the withdrawal symptoms and signs. The equivalence values are only a guide and are for licit 
drugs. They should not be used for drugs from illicit sources, as the purity of these varies and 
cannot be certain.
b. Mixed agonist/antagonist.
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5.3.5.1 Codeine-based drugs
Dihydrocodeine tartrate or codeine phosphate have a short duration of 
action and have to be given several times a day (every 4–6 hours). These 
drugs have a half-life of 3.5–4.5 hours and reach a peak concentration after 
1.5–2 hours. Dihydrocodeine modified release (DHC Continus®) can be 
given every 12 hours.
It must be remembered (as with all substitute opioid prescribing) that 
these drugs are potentially toxic and the dose should be titrated against 
withdrawal symptoms and signs. Dihydrocodeine at a dose of 60–90 mg (or 
greater) three or four times a day may be required. The decision as to the 
necessity and timing of any reassessment is the forensic physician’s responsibility 
and should be based on the severity of dependence and other aspects of 
the clinical examination. 
Many forensic physicians use dihydrocodeine as substitution treatment 
(Stark & Gregory, 2005). Although the drug is not licensed for the treatment 
of drug dependence it is efficacious for this environment (Robertson et al, 
2006). The advantage of dihydrocodeine over the other opioid substitutes 
is that it is less potent and has a shorter half-life, so that the likelihood of 
accidental accumulation or overdose is reduced. 
5.3.5.2 Methadone
Methadone is available in liquid form for the treatment of dependence. 
Initiation of methadone substitution treatment in custody will be an 
exceptional necessity; the following applies mainly to detainees already 
on prescribed methadone.
Forensic physicians are reminded that liquid methadone for the 
treatment of opioid dependence is available in a number of strengths: the 
usual form is methadone oral solution 1 mg/ml, which is typically green 
although there is a colour-free mixture; methadone oral concentrate is 
available in two strengths: 10 mg/ml (blue) and 20 mg/ml (brown). 
Care is required when authorising and dispensing previously prescribed 
methadone to ensure that the correct strength is provided, since any 
confusion could lead to overdose.
Methadone oral solution 1 mg/ml should be prescribed and need only 
be given once daily following stabilisation. Peak concentration is achieved 
4 hours after consumption and the drug has a half-life of 10–25 hours after 
a single dose and 13–55 hours after repeated doses.
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Any doctor can prescribe methadone and most other opioids to a drug 
misuser. (A special licence is required only for the prescription of cocaine, 
dipipanone and diamorphine for the purpose of treating addiction.)
If there is doubt about the dose of methadone to be given, it should be 
divided and the detainee’s condition should be reviewed after a proportion 
has been administered. It is important to document this procedure and 
why the dosage has been split, as would be the case in all other secure 
environments.
5.3.5.3 Buprenorphine
Increasingly, forensic physicians are asked to assess detainees who are on 
buprenorphine sublingual tablets, which are licensed in the UK for the 
treatment of opioid dependence. The drug is an opioid with agonist and 
antagonist properties claimed to be less of a risk in overdose when taken 
alone. The tablets are available in 0.4 mg, 2 mg and 8 mg strengths.
Direct equivalence between buprenorphine and methadone is difficult 
to estimate. However, 12–16 mg of buprenorphine is approximately as 
effective as 50–80 mg methadone in reducing heroin use and retaining 
patients in treatment. Buprenorphine is usually administered once a day 
because of its long duration of action.
As long as it is clinically safe to do so, a prescribed course of 
buprenorphine, if verifiable, should be continued while in custody, 
regardless of whether it is prescribed for detoxification or maintenance.
Self-administration of the drug must be personally supervised by the 
forensic physician, who should observe the patient to ensure that the 
drug has fully dissolved in the mouth. This may take 5–10 minutes. Care 
should be taken with the concomitant use of other sedating drugs such as 
benzodiazepines, antipsychotics and tricyclic antidepressants.
Precipitation of opioid withdrawal can occur in someone commencing 
buprenorphine who is dependent on large doses of opioids or other opioid 
analgesics. Initiation of treatment of opioid withdrawal with buprenor-
phine in police custody is not therefore recommended. It should also be 
remembered that dihydrocodeine will not be effective if an individual is 
currently taking buprenorphine.
5.3.5.4 Buprenorphine with naloxone
These drugs in combination (as 2 mg/0.5 mg and 8 mg/2 mg) are licensed 
as substitution treatment for opioid dependence. Forensic physicians 
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should confirm the dose and frequency of administration before authorising 
self-administration, which they should supervise.
5.4 Stimulants
5.4.1 Intoxication
Effects of intoxication with stimulants such as cocaine and amphetamine 
include, at low doses, euphoria, insomnia, dry mouth, hyperthermia, 
tachycardia, hypertension, increased respiration, sweating and dilated 
pupils. With increasing doses, irritability, impulsiveness, aggressiveness, 
agitated delirium, paranoia, delusions and seizures may occur.
Long-term users of cocaine or amphetamines may experience the 
syndrome of excited delirium (Wetli & Fishbain, 1985). This comprises 
four successive stages: hyperthermia, delirium, respiratory arrest and death. 
Individuals are highly agitated and paranoid, die suddenly and in some 
cases have been restrained in police custody because of excited behaviour 
shortly before death. If excited delirium is suspected, the detainee should 
be transferred to an emergency (A&E) department immediately. 
5.4.2 Withdrawal from stimulants
Stimulants such as amphetamines, ecstasy and cocaine can cause 
psychological dependence but do not produce a major physical withdrawal 
syndrome.
Withdrawal from such drugs is best achieved by discontinuation. 
Insomnia and depression may require symptomatic treatment and 
close supervision while in custody, in conjunction with assessment and 
management of suicide risk.
There is no indication in the British National Formulary for the use of 
CNS stimulant drugs for the treatment of substance misuse.
5.5 Hallucinogens
Hallucinogenic drugs such as lysergic acid diethylamide (LSD) do not cause 
physiological dependence. They may be discontinued abruptly. Subsequent 
psychological disturbances (such as anxiety) may require treatment.
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LSD is usually taken orally and results in sympathomimetic effects 
such as tachycardia, hypertension, pyrexia and dilated pupils within 10–30 
minutes, with psychological effects after 30–60 minutes. There is a recovery 
period of up to 12 hours, during which there may be periods of normal 
perception and cognition alternating with degrees of intoxication that 
may affect fitness for interview. Emotional lability, euphoria and anxiety, 
visual and auditory illusions (although true hallucinations can occur) and 
synaesthesia (a mixing of the sensory input: ‘seeing’ sounds or ‘hearing’ 
smells) may all occur. Polydrug users may use benzodiazepines to alleviate 
anxiety and panic attacks. 
LSD is a Class A controlled drug under the Misuse of Drugs Act 1971 
and its possession is illegal.
5.6 Volatile substances
Volatile substance misuse is the deliberate inhalation of fumes given off by 
volatile substances (solvents) in order to achieve intoxication. The smell of 
solvents may be noticed on the detainee’s clothing or breath, and regular 
users may have nasal sores.
Effects begin within 1 minute and may only last for 15–45 minutes; they 
are similar to the effects of sedative/hypnotic drug intoxication, resulting 
in CNS depression and alcohol-like intoxication, although with more 
perceptual distortions and sometimes frank hallucinations. Tolerance and 
psychological dependence may develop with regular use.
Forensic physicians are reminded that sudden death is a recognised 
hazard of volatile substance misuse and may occur during exposure or in 
the subsequent hours (Shepherd, 1989), especially during struggling or 
arousal.
No specific management is required, even after abrupt discontinuation. 
There is no physical withdrawal syndrome.
5.7 Cannabis
Cannabis intoxication results in euphoria and psychomotor impairment, 
with incoordination, dysarthria and ataxia. There may be cognitive 
impairment and precipitation or aggravation of psychotic states. Mild 
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withdrawal symptoms may occur, with disturbed sleep, irritability and 
restlessness. No specific treatment is required.
Synthetic cannabinoid receptor agonists are often sold in herbal 
products such as the smoking mixture ‘Spice’.
5.8 Other substances (see Stark & Norfolk, 2011)
New psychoactive substances are constantly being identified. Since the last 
edition of these guidelines, there has been a proliferation in the number 
of emerging drugs. These include: cathinones such as mephedrone 
(Advisory Council on the Misuse of Drugs, 2010); piperazines such as 
benzylpiperazine (Advisory Council on the Misuse of Drugs, 2008); 
naphyrone (naphthylpyrovalerone); and ‘ivory wave’ (desoxypipradrol, 
2-diphenylmethylpiperidine, or 2-DPMP). Often referred to as ‘legal highs’, 
these drugs are rapidly brought under legislative control if a certain level 
of harm is recognised. 
With so many new psychoactive substances available, often of 
variable content and unknown individual tolerance, and intentional 
and unintentional polydrug use, forensic physicians and healthcare 
professionals should have a low threshold, if concerned, for early referral 
to an emergency department. 
Up-to-date specific drug information on new substances is available 
from the National Poisons Information Service (www.toxbase.org). The 
European Monitoring Centre for Drugs and Drug Addiction (2010) is 
monitoring the availability and possible health impact of known and 
emerging substances.
Many of these new psychoactive substances may influence a detainee’s 
fitness for interview. After being in a stimulated/agitated state for a 
prolonged period, a detainee may require rest, which could affect the legal 
aspects of the required period of detention.
Alkyl nitrites, volatile, yellowish, clear liquids that have vasodilatory 
properties, are used as a euphoric relaxant in the dance culture and to 
relax the anal sphincter and enhance sexual performance. The effect 
of inhaling the vapour is instantaneous and very short-lived, resulting in 
a ‘rush’, but adverse effects such as dizziness, flushing, tachycardia and 
palpitations, headache, cold sweats and hypotension may occur. It is not 
illegal to possess these drugs.
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Ecstasy (3,4-methylenedioxymethamphetamine) is used orally as a 
recreational drug in the dance culture or ‘rave’ scene for its central stimulant 
and psychedelic effects. Adverse effects such as a polydipsia, hyponatraemia 
and catatonic stupor have been reported. Other adverse effects have been 
described, including flashbacks and psychosis, hyperthermia, coagulopathy, 
rhabdomyolysis, and cardiovascular complications resulting in death. 
Ecstasy is a Class A drug under Schedule 1 of the Misuse of Drugs Act 1971 
(1977 Modification Order) and its possession is illegal.
Gamma-hydroxybutyrate (GHB) is structurally related to gamma-
aminobutyric acid (GABA). It is a naturally occurring substance in the 
human brain and may be a neurotransmitter. Gamma-butyrolactone (GBL) 
is inactive but is rapidly converted to GHB when ingested. It is available as 
a colourless, odourless liquid, powder or capsules, taken orally and rarely 
injected. Initial effects include: euphoria, followed by profound sedation, 
confusion, agitation and amnesia; nausea, vomiting and diarrhoea; ataxia, 
seizures, hypotonia and tremor; vertigo and dizziness; bradycardia, 
hypotension, hypothermia; and coma and respiratory collapse. There 
is a narrow margin between intoxication and coma. The clinical effects 
are potentiated by use of other CNS depressants such as alcohol, opioids, 
benzodiazepines and antipsychotics. Dependence may occur rapidly, 
resulting in a withdrawal syndrome of anxiety, sweating, tachycardia, tremor 
and eventually delirium. Withdrawal should be treated with high-dose 
benzodiazepines. Both GHB and GBL are now controlled under Class C 
of the Misuse of Drugs Act 1971.
Khat consists of the young leaves of the Catha edulis plant. Its main 
components are cathine and cathinone, with effects similar to those of 
amphetamine. It is usually chewed for its stimulant effect, resulting in 
euphoria, increased alertness and anorexia; anxiety and insomnia may 
occur. Although both cathine and cathinone are controlled substances, it 
is not illegal to possess khat in the plant form.
Ketamine is a commercially available anaesthetic for intravenous and 
intramuscular use, but it can be found on the street in powder, tablet and 
liquid form. It can be smoked or taken intranasally (‘snorted’), as well as 
orally, intramuscularly or intravenously. It contains analgesic properties; 
the onset of effects depends on the route of administration. Ketamine is a 
prescription-only medicine, controlled under Class C of the Misuse of Drugs 
Act 1971. Physical effects may include a cocaine-like rush, hypertension, 
arrhythmias, nausea and vomiting, slurred speech, nystagmus, lack of 
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coordination and seizures. Respiratory depression may occur, and this 
can be a particular problem when ketamine is taken with other respiratory 
depressant drugs such as benzodiazepines and alcohol.
Hallucinogenic mushrooms (European Monitoring Centre for Drugs 
and Drug Addiction, 2006) grow wild in many areas of Europe and the 
USA, although more commonly they are cultivated, and their use has 
been increasing. The mushrooms are usually eaten or made into tea. 
Their effects, due to psilocybin and psilocin, are unpredictable and, as 
they include nausea and panic attacks, limit their recreational popularity. 
5.8.1 Nicotine 
The vast majority of smokers can refrain from smoking for a period, but it 
should be remembered that the effects of withdrawal from any substance, 
including nicotine, are likely to be exacerbated by the circumstances 
of acute enforced detention and may affect the legal process. Many of 
the features of nicotine withdrawal are indistinguishable from anxiety. 
Certainly, craving for nicotine can result in dysphoria and threats of self-
harm.
Nicotine replacement treatment should be available for detainees in 
police custody.
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Appendix A: PACE Code C observation list
Annex H – Detained Person: Observation List, as outlined in Code C of 
the Codes of Practice July 2006 to the Police and Criminal Evidence Act 
1984 (s.66(1)).
1. If any detainee fails to meet any of the following criteria, an appropriate 
health care professional or an ambulance must be called.
2. When assessing the level of rousability, consider:
Rousability – can they be woken?
 go into the cell
 call their name
 shake gently
Response to questions – can they give appropriate answers to questions 
such as:
 What’s your name?
 Where do you live?
 Where do you think you are?
Response to commands – can they respond appropriately to commands 
such as:
 Open your eyes!
 Lift one arm, now the other arm!
3. Remember to take into account the possibility or presence of other 
illnesses, injury, or mental condition, a person who is drowsy and smells 
of alcohol may also have the following:
 Diabetes
 Epilepsy
 Head injury
 Drug intoxication or overdose
 Stroke
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Appendix B: Metropolitan Police Form 170
The form on the following pages (Form 170) is used in the London 
Metropolitan Area to facilitate medical referrals and the transfer of 
information between the healthcare professional and the hospital doctor.
57
58
CONFIDENTIAL 
 Form 170 
Part B 
 
Detainee released from hospital care – notification to police of treatment administered 
 
Patient’s Consent: Do you give your consent for relevant medical information and/or treatment plans to be 
communicated by healthcare professionals to the Metropolitan Police Service, so that your medical welfare 
whilst in custody is maintained? 
 
Yes  No  (tick appropriate box) 
 
Signed……………………………………………………………………………………………………………………………………………………………… Date…….……../…….……../………….……… 
 
Hospital Medical Staff – advice on completion 
 
Please complete this form and hand it to the escorting police officer in a sealed envelope for the attention of the 
Healthcare Professional/Custody Officer. Please ensure that you explain clearly to the escorting police officer any 
relevant information which may be of assistance in ensuring the safety of the detainee or others. 
 CONFIDENTIAL INFORMATION SHOULD NOT BE DISCLOSED WITHOUT CONSENT. 
 
Hospital…………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
Dept.………………………………………………………………………………………………………………………………………..………………… Date…………………………………………………………… 
To: 
Forensic Medical Examiner / Healthcare Professional/Custody Officer 
Full name of patient……………………………………………………………………………………………………………………………………………………………………………………………………… 
Discharged at     hours on…………………………………………………………………………………………(date) 
 
Brief details of symptoms  
 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
 
Diagnosis  
 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
 
Details of treatment and investigations  
 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
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CONFIDENTIAL 
 Form 170 
Part B contd 
 
Medication administered 
Medication Dose Time Given 
   
   
   
   
   
   
 
Recommended after-care (to include medication – any recommendations as to police action) 
Please supply medication that the patient requires and give to police. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
 
The Forensic Medical Examiner / Healthcare Professional will be called to examine the detainee on arrival at the police 
station. 
Do you wish the FME / Healthcare Professional to contact you? Yes  No  (tick appropriate box) 
 
Signature………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
Name in BLOCK capitals………………………………………………………………………………………………………………………….. Grade……………………………………………… 
Tel. No.……………………………………………………………………………………………………… Ext.…………………………………………………………………………………………………………….. 
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CONFIDENTIAL 
 Form 170 
Part C 
 
Medical Information (to be retained at custody facility) 
 
Name…………………………………………………………………………………………………………………………………………………………………………………………………………………………………. 
This person is suffering from: 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
He / She is having the following treatment: 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. 
Further details may be obtained from: 
 
Name of Doctor / Healthcare Professional (BLOCK CAPITALS)………………………………………………………………………………………………………………… 
Telephone No.……………………………………………………………………………………………………………………………………………………………………………………………………………….. 
Signature………………………………………………………………………………………………………………………………………………………… Grade……………………………………………… 
 
Date and 
Times Further Management Doctor 
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 Form 170 
Part C contd 
 
Date and 
Times Further Management Doctor 
   
   
   
   
   
   
   
   
   
   
   
 
Retention period: 7 years 
MP 123/09 
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Appendix C: Glossary
ACPO Association of Chief Police Officers
AFP  Association of Forensic Physicians
APS  Association of Police Surgeons
CEWS Custody Early Warning Score
CFM  clinical forensic medicine 
Ecstasy see MDMA
FFLM Faculty of Forensic and Legal Medicine
FME forensic medical examiner
FMO  forensic medical officer
FP  forensic physician
GBL gamma-butyrolactone
GHB  gamma-hydroxybutyrate 
GMC  General Medical Council 
HCP healthcare professional 
HMIC Her Majesty’s Inspectorate of Constabulary
HMIP Her Majesty’s Inspectorate of Prisons
HPC  Health Professions Council
Ivory wave  desoxypipradrol/2-diphenylmethylpiperidine 2-DPMP
MDMA  ecstasy 3,4-methylenedioxymethamphetamine
MEWS Modified Early Warning Score
NMC  Nursing and Midwifery Council
NDTMS  National Drug Treatment Monitoring System 
NIDMD  Northern Ireland Drug Misuse Database 
NSPIS  National Strategy for Police Information Systems
PACE  Police and Criminal Evidence Act 1984
PGD patient group direction
RDMDs Regional Drug Misuse Databases
SDMD  Scottish Drug Misuse Database
SIDT  suspected internal drug traffickers
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